Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Previous issues

Page Path
HOME > Browse articles > Previous issues
19 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 15(2); April 2017
Prev issue Next issue
Editorials
Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
Chang Soo Eun
Intest Res 2017;15(2):145-146.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.145
PDFPubReaderePub
  • 4,429 View
  • 37 Download
  • 1 Web of Science
Close layer
Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
Jong Pil Im
Intest Res 2017;15(2):147-148.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.147
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Long-term outcome of stem cell transplantation with and without anti-tumor necrotic factor therapy in perianal fistula with Crohn’s disease
    Min Young Park, Yong Sik Yoon, Jae Ha Park, Jong Lyul Lee, Chang Sik Yu
    World Journal of Stem Cells.2024; 16(3): 257.     CrossRef
  • Epidemiology, Disease Course, and Clinical Outcomes of Perianal Fistulas and Fissures Crohn’s Disease: A Nationwide Population-Based Study in Taiwan
    Meng-Tzu Weng, Kuan-Lin Lin, Ya-Ling Huang, Chitra Karki, Jin-Liern Hong, Dimitri Bennett, K Arnold Chan, Shu-Chen Wei
    Crohn's & Colitis 360.2023;[Epub]     CrossRef
  • Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies
    Qian Cai, Zhijie Ding, Alex Z. Fu, Aarti A. Patel
    BMC Gastroenterology.2022;[Epub]     CrossRef
  • Surgical options for perianal fistula in patients with Crohn's disease: A comparison of seton placement, fistulotomy, and stem cell therapy
    Min Young Park, Yong Sik Yoon, Hyoung Eun Kim, Jong Lyul Lee, In Ja Park, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim
    Asian Journal of Surgery.2021; 44(11): 1383.     CrossRef
  • Comparative perianal fistula closure rates following autologous adipose tissue-derived stem cell transplantation or treatment with anti-tumor necrosis factor agents after seton placement in patients with Crohn’s disease: a retrospective observational stud
    Min Young Park, Yong Sik Yoon, Jong Lyul Lee, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Chang Sik Yu
    Stem Cell Research & Therapy.2021;[Epub]     CrossRef
  • Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
    Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
    Gut and Liver.2018; 12(5): 544.     CrossRef
  • 5,388 View
  • 55 Download
  • 6 Web of Science
  • 6 Crossref
Close layer
Systematic Review
Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis
Saurabh Kedia, Raju Sharma, Vishnubhatla Sreenivas, Kumble Seetharama Madhusudhan, Vishal Sharma, Sawan Bopanna, Venigalla Pratap Mouli, Rajan Dhingra, Dawesh Prakash Yadav, Govind Makharia, Vineet Ahuja
Intest Res 2017;15(2):149-159.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.149
AbstractAbstract PDFPubReaderePub

Abdominal computed tomography (CT) can noninvasively image the entire gastrointestinal tract and assess extraintestinal features that are important in differentiating Crohn's disease (CD) and intestinal tuberculosis (ITB). The present meta-analysis pooled the results of all studies on the role of CT abdomen in differentiating between CD and ITB. We searched PubMed and Embase for all publications in English that analyzed the features differentiating between CD and ITB on abdominal CT. The features included comb sign, necrotic lymph nodes, asymmetric bowel wall thickening, skip lesions, fibrofatty proliferation, mural stratification, ileocaecal area, long segment, and left colonic involvements. Sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio (DOR) were calculated for all the features. Symmetric receiver operating characteristic curve was plotted for features present in >3 studies. Heterogeneity and publication bias was assessed and sensitivity analysis was performed by excluding studies that compared features on conventional abdominal CT instead of CT enterography (CTE). We included 6 studies (4 CTE, 1 conventional abdominal CT, and 1 CTE+conventional abdominal CT) involving 417 and 195 patients with CD and ITB, respectively. Necrotic lymph nodes had the highest diagnostic accuracy (sensitivity, 23%; specificity, 100%; DOR, 30.2) for ITB diagnosis, and comb sign (sensitivity, 82%; specificity, 81%; DOR, 21.5) followed by skip lesions (sensitivity, 86%; specificity, 74%; DOR, 16.5) had the highest diagnostic accuracy for CD diagnosis. On sensitivity analysis, the diagnostic accuracy of other features excluding asymmetric bowel wall thickening remained similar. Necrotic lymph nodes and comb sign on abdominal CT had the best diagnostic accuracy in differentiating CD and ITB.

Citations

Citations to this article as recorded by  
  • Differentiation of Crohn's disease, ulcerative colitis, and intestinal tuberculosis by dual-layer spectral detector CT enterography
    M. Huang, L. Tu, J. Li, X. Yue, L. Wu, M. Yang, Y. Chen, P. Han, X. Li, L. Zhu
    Clinical Radiology.2024; 79(3): e482.     CrossRef
  • Deep Learning Radiomics Analysis of CT Imaging for Differentiating Between Crohn’s Disease and Intestinal Tuberculosis
    Ming Cheng, Hanyue Zhang, Wenpeng Huang, Fei Li, Jianbo Gao
    Journal of Imaging Informatics in Medicine.2024; 37(4): 1516.     CrossRef
  • New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis
    Himanshu Narang, Saurabh Kedia, Vineet Ahuja
    Current Opinion in Infectious Diseases.2024;[Epub]     CrossRef
  • Management and monitoring of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management,
    Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen Calixto Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw
    Journal of Gastroenterology and Hepatology.2023; 38(4): 510.     CrossRef
  • Granulomatous bowel disease: Crohn’s disease and tuberculosis. Difficulties in differential diagnosis (case report and review)
    A. V. Vardanyan, E. S. Merkulova, V. A. Belinskaya, K. S. Frolova, O. A. Mainovskaya
    Koloproktologia.2023; 22(1): 117.     CrossRef
  • Evidence-based approach to diagnosis and management of abdominal tuberculosis
    Daya Krishna Jha, Mythili Menon Pathiyil, Vishal Sharma
    Indian Journal of Gastroenterology.2023; 42(1): 17.     CrossRef
  • Differentiating gastrointestinal tuberculosis and Crohn's disease- a comprehensive review
    Arup Choudhury, Jasdeep Dhillon, Aravind Sekar, Pankaj Gupta, Harjeet Singh, Vishal Sharma
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests
    Preeti Mor, Bhawna Dahiya, Sanjeev Parshad, Pooja Gulati, Promod K. Mehta
    Expert Review of Gastroenterology & Hepatology.2022; 16(1): 33.     CrossRef
  • Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
    Saurabh Kedia, Raju Sharma, Sudheer Kumar Vuyyuru, Deepak Madhu, Pabitra Sahu, Bhaskar Kante, Prasenjit Das, Ankur Goyal, Karan Madan, Govind Makharia, Vineet Ahuja
    Intestinal Research.2022; 20(2): 184.     CrossRef
  • Systematic reporting of computed tomography enterography/enteroclysis as an aid to reduce diagnostic dilemma when differentiating between intestinal tuberculosis and Crohn's disease: A prospective study at a tertiary care hospital
    Amrin Israrahmed, Rajanikant R Yadav, Geeta Yadav, Alpana, Rajesh V Helavar, Praveer Rai, Manoj Kumar Jain, Archna Gupta
    JGH Open.2021; 5(2): 180.     CrossRef
  • Intestinal Tuberculosis: A Diagnostic Challenge
    Hansang Park, Tikal Kansara, Ana M Victoria, Noella Boma, Jungrak Hong
    Cureus.2021;[Epub]     CrossRef
  • Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion
    Saurabh Kedia, Vineet Ahuja
    JGH Open.2021; 5(2): 177.     CrossRef
  • Deep‐learning system for real‐time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis
    Jung Min Kim, Jun Gu Kang, Sungwon Kim, Jae Hee Cheon
    Journal of Gastroenterology and Hepatology.2021; 36(8): 2141.     CrossRef
  • Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
    Ritika Rampal, Saurabh Kedia, Mohamad Nahidul Wari, Deepak Madhu, Amit Kumar Singh, Veena Tiwari, V. Pratap Mouli, Srikant Mohta, Govind Makharia, Vineet Ahuja
    Intestinal Research.2021; 19(2): 232.     CrossRef
  • Correlation-driven framework based on graph convolutional network for clinical disease classification
    Kai Cao, Ying Xiao, Muzhou Hou
    Journal of Statistical Computation and Simulation.2021; 91(15): 3108.     CrossRef
  • Difficulties in the differential diagnosis of intestinal tuberculosis and Crohn‘s disease
    M. N. Reshetnikov, D. V. Plotkin, Yu. R. Zyuzya, A. A. Volkov, O. N. Zuban, E. M. Bogorodskaya
    Acta Biomedica Scientifica.2021; 6(5): 196.     CrossRef
  • Diagnostic performance of CT for differentiating peritoneal tuberculosis from peritoneal carcinomatosis: a systematic review and meta-analysis
    J. Chen, S. Liu, Y. Tang, X. Zhang, M. Cao, Z. Xiao, M. Ren, T. Chen
    Clinical Radiology.2020; 75(5): 396.e7.     CrossRef
  • Disseminated tuberculosis presenting as massive lower gastrointestinal bleeding
    Nehal Aggarwal, SubodhKumar Mahto, Akanskha Singh, Kritika Gupta, Ankita Aneja, Anu Singh, Atul Goel
    Journal of Family Medicine and Primary Care.2020; 9(2): 1226.     CrossRef
  • Differentiating Crohn’s disease from intestinal tuberculosis
    Saurabh Kedia, Prasenjit Das, Kumble Seetharama Madhusudhan, Siddhartha Dattagupta, Raju Sharma, Peush Sahni, Govind Makharia, Vineet Ahuja
    World Journal of Gastroenterology.2019; 25(4): 418.     CrossRef
  • The potential role of CT enterography and gastrointestinal ultrasound in the evaluation of anti-tubercular therapy response of intestinal tuberculosis: a retrospective study
    Li Ma, Qingli Zhu, Yue Li, Wenbo Li, Xuan Wang, Wei Liu, Jianchu Li, Yuxin Jiang
    BMC Gastroenterology.2019;[Epub]     CrossRef
  • Indian guidelines on imaging of the small intestine in Crohn’s disease: A joint Indian Society of Gastroenterology and Indian Radiology and Imaging Association consensus statement
    Saurabh Kedia, Raju Sharma, Govind Makharia, Vineet Ahuja, Devendra Desai, Devasenathipathy Kandasamy, Anu Eapen, Karthik Ganesan, Uday C Ghosha, Naveen Kalra, R Karthikeyan, Kumble Seetharama Madhusudhan, Mathew Philip, Amarender Puri, Sunil Puri, Saroj
    Indian Journal of Radiology and Imaging.2019; 29(02): 111.     CrossRef
  • Imaging in discriminating intestinal tuberculosis and Crohn’s disease: past, present and the future
    Pradeep Goyal, Jimil Shah, Sonali Gupta, Pankaj Gupta, Vishal Sharma
    Expert Review of Gastroenterology & Hepatology.2019; 13(10): 995.     CrossRef
  • Combination of increased visceral fat and long segment involvement: Development and validation of an updated imaging marker for differentiating Crohn's disease from intestinal tuberculosis
    Saurabh Kedia, Kumble S Madhusudhan, Raju Sharma, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Saransh Jain, Prasenjit Das, Siddhartha Dattagupta, Govind Makharia, Vineet Ahuja
    Journal of Gastroenterology and Hepatology.2018; 33(6): 1234.     CrossRef
  • Computed Tomography Enterography: Quantitative Evaluation on Crohn’s Disease Activity
    Jingyun Cheng, Hui Xie, Hao Yang, Ke Wang, Guobin Xu, Guangyao Wu
    Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
  • Gastrointestinal Tuberculosis Presenting as Malnutrition and Distal Colonic Bowel Obstruction
    Raja Chandra Chakinala, Zahava C. Farkas, Benjamin Barbash, Khwaja F. Haq, Shantanu Solanki, Muhammad Ali Khan, Edward Esses, Taliya Farooq, Brad Dworkin
    Case Reports in Gastrointestinal Medicine.2018; 2018: 1.     CrossRef
  • Diagnostic point-of-care ultrasound (POCUS) for gastrointestinal pathology: state of the art from basics to advanced
    Fikri M Abu-Zidan, Arif Alper Cevik
    World Journal of Emergency Surgery.2018;[Epub]     CrossRef
  • Enfermedad de Crohn vs tuberculosis intestinal: un diagnóstico diferencial desafiante. Revisión de tema
    Gabriel Alonso Mosquera-Klinger, Andrea Ucroz Benavides
    Revista Colombiana de Gastroenterología.2018; 33(4): 423.     CrossRef
  • Imaging of the small intestine in Crohn’s disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association
    Saurabh Kedia, Raju Sharma, Govind K. Makharia, Vineet Ahuja, Devendra Desai, Devasenathipathy Kandasamy, Anu Eapen, Karthik Ganesan, Uday C. Ghoshal, Naveen Kalra, D. Karthikeyan, Kumble Seetharama Madhusudhan, Mathew Philip, Amarender Singh Puri, Sunil
    Indian Journal of Gastroenterology.2017; 36(6): 487.     CrossRef
  • Editor’s Pick: Recent Advances in the Diagnosis and Management of Abdominal Tuberculosis
    Harshal S. Mandavdhare, Harjeet Singh, Vishal Sharma
    EMJ Gastroenterology.2017; : 52.     CrossRef
  • 8,008 View
  • 136 Download
  • 26 Web of Science
  • 29 Crossref
Close layer
Reviews
Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls
Paulo Gustavo Kotze, Subrata Ghosh, Willem A. Bemelman, Remo Panaccione
Intest Res 2017;15(2):160-165.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.160
AbstractAbstract PDFPubReaderePub

Recent advances in medical and surgical therapy were achieved during the last two decades in the management of Crohn's disease (CD). Anti-tumor necrosis factor (anti-TNF) agents are widely used worldwide. However, a significant proportion of patients still need surgical resections. The impact of previous exposure to these agents on the perioperative and postoperative outcomes is still controversial. In this critical review, we aimed to position the strategy of intentional preoperative use of anti-TNF agents in the management of CD. The indications and contraindications for this strategy are detailed, and despite scarce evidence, the possible advantages and disadvantages of the intentional use of anti-TNF agents before abdominal surgery in CD are discussed.

Citations

Citations to this article as recorded by  
  • Clinical guidelines. Crohn’s disease (К50), adults
    Yury A. Shelygin, Vladimir T. Ivashkin, Sergey I. Achkasov, Igor V. Reshetov, Igor V. Maev, Elena A. Belousova, Armen V. Vardanyan, Bella A. Nanaeva, Leila V. Adamyan, Oksana M. Drapkina, Leila S. Namazova-Baranova, Aleksandr Yu. Razumovsky, Amiran Sh. Re
    Koloproktologia.2023; 22(3): 10.     CrossRef
  • Surgical Management of Small Bowel Crohn's Disease
    Pramodh Chandrasinghe
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Exploring the Relationship between Biologics and Postoperative Surgical Morbidity in Ulcerative Colitis: A Review
    Abel Botelho Quaresma, Fernanda da Silva Barbosa Baraúna, Fábio Vieira Teixeira, Rogério Saad-Hossne, Paulo Gustavo Kotze
    Journal of Clinical Medicine.2021; 10(4): 710.     CrossRef
  • The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn’s Disease
    Amy L. Lightner, Jon D. Vogel, Joseph C. Carmichael, Deborah S. Keller, Samir A. Shah, Uma Mahadevan, Sunanda V. Kane, Ian M. Paquette, Scott R. Steele, • Daniel L. Feingold
    Diseases of the Colon & Rectum.2020; 63(8): 1028.     CrossRef
  • Enterocutaneous fistula in severely active Crohn’s disease: preoperative anti-TNF alpha treatment to limit bowel resection—report of a case
    Peter Wilhelm, Andreas Kirschniak, Jonas Johannink, Sascha Kaufmann, Thomas Klag, Jan Wehkamp, Claudius Falch
    International Journal of Colorectal Disease.2019; 34(2): 369.     CrossRef
  • Management of Biological Therapy Before Elective Inflammatory Bowel Disease Surgeries
    Tawnya M Hansen, Laura E Targownik, Ahmer Karimuddin, Yvette Leung
    Inflammatory Bowel Diseases.2019; 25(10): 1613.     CrossRef
  • Gestion périopératoire des biothérapies en 2019
    Thibault Martinez, Jean Derely, Astrée Swiech, Gaël de Roquigny, Charlotte Delattre, Frederic Banal, Mehdi Ould-Ahmed, Diane Commandeur
    Anesthésie & Réanimation.2019; 5(4): 274.     CrossRef
  • Biological Treatment and the Potential Risk of Adverse Postoperative Outcome in Patients With Inflammatory Bowel Disease: An Open-Source Expert Panel Review of the Current Literature and Future Perspectives
    Alaa El-Hussuna, Pär Myrelid, Stefan D Holubar, Paulo G Kotze, Graham Mackenzie, Gianluca Pellino, Des Winter, Justin Davies, Ionut Negoi, Perbinder Grewal, Gaetano Gallo, Kapil Sahnan, Ines Rubio-Perez, Daniel Clerc, Nicolas Demartines, James Glasbey, Mi
    Crohn's & Colitis 360.2019;[Epub]     CrossRef
  • Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis
    Paulo Gustavo Kotze, Christopher Ma, Nicholas Mckenna, Abdulelah Almutairdi, Gilaad G. Kaplan, Laura E. Raffals, Edward V. Loftus, Remo Panaccione, Amy L. Lightner
    Therapeutic Advances in Gastroenterology.2018; 11: 175628481878361.     CrossRef
  • Emerging Therapies: What Are Promising in the Near Future?
    Geom Seog Seo, Sung Hee Lee
    The Korean Journal of Gastroenterology.2018; 71(2): 81.     CrossRef
  • Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional Support
    Patrick L. Stoner, Amir Kamel, Fares Ayoub, Sanda Tan, Atif Iqbal, Sarah C. Glover, Ellen M. Zimmermann
    Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
  • 5,353 View
  • 56 Download
  • 9 Web of Science
  • 11 Crossref
Close layer
Current status of endoscopic balloon dilation for Crohn's disease
Fumihito Hirai
Intest Res 2017;15(2):166-173.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.166
AbstractAbstract PDFPubReaderePub

The therapeutic target in Crohn's disease (CD) has been raised to the achievement of mucosal healing. Although effective treatments that target cytokines and other molecules has been widely used for CD, intestinal strictures are still a major cause of surgery. Endoscopic balloon dilation (EBD) is known to be an effective and safe intervention for intestinal strictures in CD. Since frequent intestinal resection often results in short bowel syndrome and can decrease the quality of life, EBD can help avoid surgery. EBD with a conventional colonoscope for Crohn's strictures of the colon and ileo-colonic anastomosis has established efficacy and safety. In addition, EBD using balloon-assisted enteroscopy has recently been applied for small bowel Crohn's strictures. Although the evidence is not strong, EBD may become an alternative to surgery in small bowel strictures in CD. EBD and other new methods such as self-expanding stent implantation for Crohn's strictures may be useful and safe; however, it is important to address several issues regarding these interventions and to establish a protocol for combined therapies.

Citations

Citations to this article as recorded by  
  • Short-term outcomes of bariatric surgery in patients with inflammatory bowel disease: a national analysis
    Russyan Mark Mabeza, Amulya Vadlakonda, Nikhil Chervu, Shayan Ebrahimian, Sara Sakowitz, Amy Yetasook, Peyman Benharash
    Surgery for Obesity and Related Diseases.2024; 20(2): 146.     CrossRef
  • Efficacy and Safety of Endoscopic Stricturotomy in Inflammatory Bowel Disease-Related Strictures: A Systematic Review and Meta-Analysis
    Fouad Jaber, Laith Numan, Mohammed Ayyad, Mohamed Abuelazm, Muhammad Imran, Majd M. AlBarakat, Aya M. Aboutaleb, Ubaid Khan, Saqr Alsakarneh, Mohammad Bilal
    Digestive Diseases and Sciences.2024;[Epub]     CrossRef
  • Factors associated with the efficacy and safety of endoscopic dilatation of symptomatic strictures in Crohn’s disease: a retrospective cohort study
    Pierre Dandoy, Edouard Louis, Pierrette Gast, Maxime Poncin, Laurence Seidel, Jean-Philippe Loly
    Scandinavian Journal of Gastroenterology.2023; 58(6): 671.     CrossRef
  • Approach to Endoscopic Balloon Dilatation in Pediatric Stricturing Crohn Disease: A Position Paper of the Endoscopy Special Interest Group of ESPGHAN
    Oren Ledder, Matjaž Homan, Raoul Furlano, Alexandra Papadopoulou, Salvatore Oliva, Jorge Amil Dias, Luigi Dall’oglio, Simona Faraci, Priya Narula, Dominique Schluckebier, Bruno Hauser, Andreia Nita, Claudio Romano, Christos Tzivinikos, Patrick Bontems, Mi
    Journal of Pediatric Gastroenterology & Nutrition.2023; 76(6): 799.     CrossRef
  • Anastomotic Configuration and Temporary Diverting Ileostomy Do Not Increase Risk of Anastomotic Stricture in Postoperative Crohn's Disease
    Salam P. Bachour, Muhammad Z. Khan, Ravi S. Shah, Abel Joseph, Hareem Syed, Adel Hajj Ali, Florian Rieder, Stefan D. Holubar, Edward L. Barnes, Jordan Axelrad, Miguel Regueiro, Benjamin L. Cohen, Benjamin H. Click
    American Journal of Gastroenterology.2023;[Epub]     CrossRef
  • Novel deformable self-assembled magnetic anastomosis ring for endoscopic treatment of colonic stenosis via natural orifice
    Miao-Miao Zhang, Guang-Bin Zhao, Han-Zhi Zhang, Shu-Qin Xu, Ai-Hua Shi, Jian-Qi Mao, Jing-Ci Gai, Yu-Han Zhang, Jia Ma, Yun Li, Yi Lyu, Xiao-Peng Yan
    World Journal of Gastroenterology.2023; 29(33): 5005.     CrossRef
  • Magnetic compression anastomosis for sigmoid stenosis treatment: A case report
    Miao-Miao Zhang, Yi Gao, Xiao-Yang Ren, Huan-Chen Sha, Yi Lyu, Fang-Fang Dong, Xiao-Peng Yan
    World Journal of Gastrointestinal Endoscopy.2023; 15(12): 745.     CrossRef
  • A Phase II Clinical Trial to Study the Safety of Triamcinolone after Endoscopic Radial Incision and Cutting Dilatation for Benign Stenosis of the Lower Gastrointestinal Tract: A Study Protocol
    RINTARO MOROI, HISASHI SHIGA, KOTARO NOCHIOKA, HIROFUMI CHIBA, YUSUKE SHIMOYAMA, MOTOYUKI ONODERA, TAKEO NAITO, MASAKI TOSA, YOICHI KAKUTA, YUICHIRO SATO, SHOICHI KAYABA, SEICHI TAKAHASHI, SATOSHI MIYATA, YOSHITAKA KINOUCHI, ATSUSHI MASAMUNE
    The Kurume Medical Journal.2023; 70(1.2): 53.     CrossRef
  • Usefulness of Fluoroscopy for Endoscopic Balloon Dilation of Crohn’s Disease-Related Strictures
    Hyun Seok Lee, Michael V. Chiorean, Elisa Boden, James Lord, Shayan Irani, Richard Kozarek, Michael Larsen, Andrew Ross
    Digestive Diseases and Sciences.2022; 67(4): 1295.     CrossRef
  • Long‐term outcomes of endoscopic balloon dilation for intestinal strictures in patients with Crohn's disease during maintenance treatment with anti‐tumor necrosis factor alpha antibodies
    Teruyuki Takeda, Masahiro Kishi, Noritaka Takatsu, Yasumichi Takada, Tsuyoshi Beppu, Masaki Miyaoka, Takashi Hisabe, Toshiharu Ueki, Hisatomi Arima, Fumihito Hirai, Kenshi Yao
    Digestive Endoscopy.2022; 34(3): 517.     CrossRef
  • A pilot study investigating the safety and feasibility of endoscopic dilation using a radial incision and cutting technique for benign strictures of the small intestine: a study protocol
    Rintaro Moroi, Hisashi Shiga, Kotaro Nochioka, Yusuke Shimoyama, Masatake Kuroha, Yoichi Kakuta, Yoshitaka Kinouchi, Atsushi Masamune
    Pilot and Feasibility Studies.2022;[Epub]     CrossRef
  • Endoscopic radial incision and cutting for benign stenosis of the lower gastrointestinal tract: An investigation of novel endoscopic treatment in multicenter trial
    Rintaro Moroi, Hisashi Shiga, Kotaro Nochioka, Hirofumi Chiba, Yusuke Shimoyama, Masatake Kuroha, Masaki Tosa, Yoichi Kakuta, Shoichi Kayaba, Seiichi Takahashi, Yoshitaka Kinouchi, Atsushi Masamune
    Journal of Gastroenterology and Hepatology.2022; 37(8): 1554.     CrossRef
  • Guidelines for endoscopic balloon dilation in treating Crohn's disease‐associated small intestinal strictures (supplement to the Clinical Practice Guidelines for Enteroscopy)
    Hironori Yamamoto, Tomonori Yano, Akihiro Araki, Motohiro Esaki, Kazuo Ohtsuka, Naoki Ohmiya, Shiro Oka, Hiroshi Nakase, Shigeki Bamba, Fumihito Hirai, Naoki Hosoe, Tomoki Matsuda, Keigo Mitsui, Kenji Watanabe, Haruhiko Ogata, Shinichi Katsuki, Takayuki M
    Digestive Endoscopy.2022; 34(7): 1278.     CrossRef
  • Managing Stricturing Crohn's Disease: Resect? Strictureplasty? Dilate?
    Lea Lowenfeld, Fabrizio Michelassi
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2021; 31(8): 881.     CrossRef
  • Crohn’s disease at radiological imaging: focus on techniques and intestinal tract
    Giuseppe Cicero, Silvio Mazziotti
    Intestinal Research.2021; 19(4): 365.     CrossRef
  • Evaluation of the endoscopic treatment with topical prednisolone administration for intestinal strictures in Crohn’s disease
    Yaroslav Feleshtynskiy, Anna Mylianovska, Volodymyr Pirogovsky, Olena Dyadyk
    Polish Journal of Surgery.2021; 94(1): 28.     CrossRef
  • Objective evaluation for treat to target in Crohn’s disease
    Kento Takenaka, Yoshio Kitazume, Toshimitsu Fujii, Kiichiro Tsuchiya, Mamoru Watanabe, Kazuo Ohtsuka
    Journal of Gastroenterology.2020; 55(6): 579.     CrossRef
  • Strictures in Crohn’s Disease: From Pathophysiology to Treatment
    Mattia Crespi, Pietro Dulbecco, Antonella De Ceglie, Massimo Conio
    Digestive Diseases and Sciences.2020; 65(7): 1904.     CrossRef
  • A Novel Capsule Endoscopic Score for Crohn’s Disease
    Teppei Omori, Takayuki Matsumoto, Toshifumi Hara, Harutaka Kambayashi, Shun Murasugi, Ayumi Ito, Maria Yonezawa, Shinichi Nakamura, Katsutoshi Tokushige
    Crohn's & Colitis 360.2020;[Epub]     CrossRef
  • Correlation between age of onset and gastrointestinal stenosis in hospitalized patients with Crohn's disease
    Shan-Bing Yang, Shu-Wen Du, Ji-Heng Wang
    World Journal of Clinical Cases.2020; 8(13): 2769.     CrossRef
  • Strictures in Crohn's Disease and Ulcerative Colitis
    Jason Reinglas, Talat Bessissow
    Gastrointestinal Endoscopy Clinics of North America.2019; 29(3): 549.     CrossRef
  • Endoscopic management of Crohn’s strictures
    Talat Bessissow, Jason Reinglas, Achuthan Aruljothy, Peter L Lakatos, Gert Van Assche
    World Journal of Gastroenterology.2018; 24(17): 1859.     CrossRef
  • Endoscopic Balloon Dilation for Crohn’s Disease-Associated Strictures
    Thomas Klag, Jan Wehkamp, Martin Goetz
    Clinical Endoscopy.2017; 50(5): 429.     CrossRef
  • Endoscopy in inflammatory bowel disease: advances in disease management
    Elizabeth A. Scoville, David A. Schwartz
    Gastrointestinal Endoscopy.2017; 86(6): 952.     CrossRef
  • 7,810 View
  • 99 Download
  • 24 Web of Science
  • 24 Crossref
Close layer
Original Articles
Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells
Yu Chuan Liu, Se Lim Kim, Young Ran Park, Soo-Teik Lee, Sang Wook Kim
Intest Res 2017;15(2):174-181.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.174
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Parthenolide (PT), a principle component derived from feverfew (Tanacetum parthenium), is a promising anticancer agent and has been shown to promote apoptotic cell death in various cancer cells. In this study, we focused on its functional role in apoptosis, migration, and invasion of human colorectal cancer (CRC) cells.

Methods

SW620 cells were employed as representative human CRC cells. We performed the MTT assay and cell cycle analysis to measure apoptotic cell death. The wound healing, Transwell migration, and Matrigel invasion assays were performed to investigate the effect of PT on cell migration/invasion. Western blotting was used to establish the signaling pathway of apoptosis and cell migration/invasion.

Results

PT exerts antiproliferative effect and induces apoptotic cell death of SW620 cells. In addition, PT prevents cell migration and invasion in a dose-dependent manner. Moreover, PT markedly suppressed migration/invasion-related protein expression, including E-cadherin, β-catenin, vimentin, Snail, cyclooxygenase-2, matrix metalloproteinase-2 (MMP-2), and MMP-9 in SW620 cells. PT also inhibited the expression of antiapoptotic proteins (Bcl-2 and Bcl-xL) and activated apoptosis terminal factor (caspase-3) in a dose-dependent manner.

Conclusions

Our results suggest that PT is a potential novel therapeutic agent for aggressive CRC treatment.

Citations

Citations to this article as recorded by  
  • Novel formulation of parthenolide-loaded liposome coated with chitosan and evaluation of its potential anticancer effects in vitro
    Parisa Karimian Ensaf, Mohammad Taghi Goodarzi, Masoud Homayouni Tabrizi, Ali Neamati, Samira Sadat Hosseinyzadeh
    Molecular Biology Reports.2024;[Epub]     CrossRef
  • Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis
    Chou-Yi Hsu, Sadegh Rajabi, Maryam Hamzeloo-Moghadam, Abhinav Kumar, Marc Maresca, Pallavi Ghildiyal
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Bitter taste signaling in cancer
    Ana R. Costa, Ana C. Duarte, Ana R. Costa-Brito, Isabel Gonçalves, Cecília R.A. Santos
    Life Sciences.2023; 315: 121363.     CrossRef
  • Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells
    Adriana S. Gehren, Waldemir F. de Souza, Annie C. M. Sousa‐Squiavinato, Diego A. A. Ramos, Bruno R. B. Pires, Eliana S. F. W. Abdelhay, Jose A. Morgado‐Diaz
    Cell Biology International.2023; 47(9): 1638.     CrossRef
  • Novel shikonin derivative suppresses tumor growth and metastasis intervention of Wnt/β-catenin pathway
    Hongwei Han, Zhongling Wen, Xiaohui Lai, Minkai Yang, Jiangyan Fu, Liangjie Yang, Qingqing Chen, Yudi Ma, Wencai Jie, Changyi Wang, Tongming Yin, Guihua Lu, Xiaoming Wang, Shucun Sun, Quan Zhao, Jinliang Qi, Hongyan Lin, Yonghua Yang
    Process Biochemistry.2023; 132: 297.     CrossRef
  • Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition
    Soad L. Kabil, Hayam E. Rashed, Noura Mostafa Mohamed, Nisreen E. Elwany
    Life Sciences.2023; 331: 122037.     CrossRef
  • TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer
    Sumeet Singh, Vinita Gouri, Mukesh Samant
    Medical Oncology.2023;[Epub]     CrossRef
  • Decoding Systems Biology of Inflammation Signatures in Cancer Pathogenesis: Pan-Cancer Insights from 12 Common Cancers
    Beste Turanli
    OMICS: A Journal of Integrative Biology.2023; 27(10): 483.     CrossRef
  • Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
    Daniela Carlisi, Marianna Lauricella, Antonella D’Anneo, Anna De Blasio, Adriana Celesia, Giovanni Pratelli, Antonietta Notaro, Giuseppe Calvaruso, Michela Giuliano, Sonia Emanuele
    Biomedicines.2022; 10(2): 514.     CrossRef
  • Parthenolide reverses the epithelial to mesenchymal transition process in breast cancer by targeting TGFbeta1: In vitro and in silico studies
    Hazera Binte Sufian, Julianna Maria Santos, Zeina S. Khan, Sobia Ahsan Halim, Ajmal Khan, Maliha Tabassum Munir, MD Khurshidul Zahid, Ahmed Al-Harrasi, Lauren S. Gollahon, Fazle Hussain, Shaikh Mizanoor Rahman
    Life Sciences.2022; 301: 120610.     CrossRef
  • Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide
    Yubo Dong, Xuanjin Qian, Jian Li, Ahmed Faeq Hussein
    Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
  • Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents
    Xingchen LIU, Xiaobing WANG
    Chinese Journal of Natural Medicines.2022; 20(11): 814.     CrossRef
  • Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
    Chin King Looi, Ling-Wei Hii, Felicia Fei-Lei Chung, Chun-Wai Mai, Wei-Meng Lim, Chee-Onn Leong
    Cancers.2021; 13(8): 1786.     CrossRef
  • Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
    Magdalena Rausch, Adriano Rutz, Pierre-Marie Allard, Céline Delucinge-Vivier, Mylène Docquier, Olivier Dormond, Paul J. Dyson, Jean-Luc Wolfender, Patrycja Nowak-Sliwinska
    Cancers.2021; 13(16): 3978.     CrossRef
  • 6 α-Hydroxy-4[14], 10[15]-guainadien-8β, 12-olide induced cell cycle arrest via modulation of EMT and Wnt/β-catenin pathway in HER-2 positive breast cancer cells
    Gitanjali Javir, Kalpana Joshi, Vijay Khedkar, Supada Rojatkar
    The Journal of Steroid Biochemistry and Molecular Biology.2020; 197: 105514.     CrossRef
  • Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth
    Xue Li, Lingmei Kong, Qihong Yang, Aizhu Duan, Xiaoman Ju, Bicheng Cai, Lin Chen, Tao An, Yan Li
    Journal of Biological Chemistry.2020; 295(11): 3576.     CrossRef
  • Metabonomic study of the intervention effects of Parthenolide on anti-thyroid cancer activity
    Lili Yuan, Zhe Wang, Dongyang Zhang, Jiahe Wang
    Journal of Chromatography B.2020; 1150: 122179.     CrossRef
  • ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF‐κB activation
    Xiao‐Han Jin, Yong‐Sheng Jia, Ye‐Hui Shi, Qiu‐Ying Li, Shi‐Qi Bao, Wen‐Ping Lu, Zhong‐Sheng Tong
    Journal of Cellular Biochemistry.2019; 120(2): 1386.     CrossRef
  • Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
    Mona Dawood, Edna Ooko, Thomas Efferth
    Frontiers in Pharmacology.2019;[Epub]     CrossRef
  • Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells
    Shi Mao Zhu, Yong Ran Park, Seung Yong Seo, In Hee Kim, Soo Teik Lee, Sang Wook Kim
    Intestinal Research.2019; 17(4): 527.     CrossRef
  • Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer
    Luksana Chaiswing, William H. St. Clair, Daret K. St. Clair
    Antioxidants & Redox Signaling.2018; 29(13): 1237.     CrossRef
  • Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression
    Wamidh H. Talib, Lina T. Al Kury
    Biomedicine & Pharmacotherapy.2018; 107: 1488.     CrossRef
  • Synergistic effects and mechanisms of impressic acid or acankoreanogein in combination with docetaxel on prostate cancer
    Sen Jiang, Kun Zhang, Yan He, Xuetao Xu, Dongli Li, Shupeng Cheng, Xi Zheng
    RSC Advances.2018; 8(5): 2768.     CrossRef
  • The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis
    Xin Jin, Jianping Zhou, Zhenhai Zhang, Huixia Lv
    Artificial Cells, Nanomedicine, and Biotechnology.2018; 46(sup3): 931.     CrossRef
  • 6,648 View
  • 88 Download
  • 27 Web of Science
  • 24 Crossref
Close layer
Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease
Cheng-Chun Ji, Shota Takano
Intest Res 2017;15(2):182-186.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.182
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Infliximab has proven to be effective in the treatment of perianal fistulas in Crohn's disease (CD) but the efficacy of adalimumab is still unclear. The aim of this study is to assess the clinical efficacy of adalimumab and compare the results with those for infliximab.

Methods

Forty-seven CD patients treated for perianal fistulas with infliximab from September 2005 to December 2010 (n=31), or with adalimumab from November 2010 to May 2012 (n=16), were enrolled in this retrospective study. The following patient characteristics were analyzed; intestinal lesion site, fistula classification, seton placement, index of inflammatory bowel disease, C-reactive protein level, follow-up period, and the cumulative rate of nonrecurrence or aggravation of fistula.

Results

There were no significant differences in the intestinal lesion site, fistula classification, inflammatory bowel disease index, C-reactive protein level, and the frequency of injection between the infliximab group and the adalimumab group. The cumulative rate of nonrecurrence or aggravation of fistula was 62.5% in the adalimumab group and 83.9% in the infliximab group at 24 months after treatment (P=0.09). The risk factors for recurrence or aggravation may be related to seton placement (P=0.02), gender (P=0.06), and fistula classification (P=0.07).

Conclusions

There was no significant difference in the clinical efficacy of adalimumab and infliximab in the treatment of perianal fistulas in CD. However, fistula classification may be an important risk factor for recurrence or aggravation. The preliminary findings in this study show that further research is warranted.

Citations

Citations to this article as recorded by  
  • Choosing Therapy for Moderate to Severe Crohn’s Disease
    Malcolm Irani, Bincy Abraham
    Journal of the Canadian Association of Gastroenterology.2024; 7(1): 1.     CrossRef
  • The use of core descriptors from the ENiGMA code study in recent literature: a systematic review
    Saher‐Zahra Khan, Andrea Arline, Kate M. Williams, Matthew J. Lee, Emily Steinhagen, Sharon L. Stein
    Colorectal Disease.2024; 26(3): 428.     CrossRef
  • The potential for medical therapies to address fistulizing Crohn’s disease: a state-of-the-art review
    Mohammad Shehab, Davide De Marco, Peter L. Lakatos, Talat Bessissow
    Expert Opinion on Biological Therapy.2024; 24(8): 733.     CrossRef
  • Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021
    Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai, Taku Kobayashi, Katsuyoshi Matsuoka, Minoru Matsuura, Makoto Naganuma, Masayuki Saruta, Kiichiro Tsuchiya, Motoi Uchino, Kenji Watanabe, Tadakazu Hisamatsu, Akira Andoh, Shigeki Bamba, Motohiro Esaki, Mikihi
    Journal of Gastroenterology.2023; 58(4): 313.     CrossRef
  • Perianal fistulas in Crohn's disease (review)
    I. S. Anosov, B. A. Nanaeva, A. V. Vardanyan, M. A. Zakharov
    Koloproktologia.2023; 22(1): 128.     CrossRef
  • Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn’s Perianal Fistulae
    Laura Maas, Ruiyi Gao, Vivy Cusumano, Ellen Spartz, Reezwana Chowdhury, Mahesh Krishna, Mark Lazarev, Joanna Melia, Florin Selaru, Sowmya Sharma, Berkeley Limketkai, Alyssa Parian
    Digestive Diseases and Sciences.2023; 68(10): 3994.     CrossRef
  • Management of Perianal Fistulizing Crohn’s Disease
    Arshdeep Singh, Vandana Midha, Gursimran Singh Kochhar, Bo Shen, Ajit Sood
    Inflammatory Bowel Diseases.2023;[Epub]     CrossRef
  • Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?
    Gustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, Alex Al Khoury, Talat Bessissow, Peter Laszlo Lakatos
    Biomedicines.2022; 10(4): 749.     CrossRef
  • The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials
    Panu Wetwittayakhlang, Alex Al Khoury, Gustavo Drügg Hahn, Peter Laszlo Lakatos
    Journal of Clinical Medicine.2022; 11(11): 3045.     CrossRef
  • Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
    Hua-Hua Yang, Yi Huang, Xu-Chun Zhou, Ruo-Nan Wang
    World Journal of Clinical Cases.2022; 10(18): 6091.     CrossRef
  • An AAV-Based NF-κB-Targeting Gene Therapy (rAAV-DMP-miR533) to Inflammatory Diseases
    Tao Luo, Yile Wang, Hailin Tang, Fei Zhou, Ying Chen, Bing Pei, Jinke Wang
    Journal of Inflammation Research.2022; Volume 15: 3447.     CrossRef
  • Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
    Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
    Gut and Liver.2021; 15(1): 92.     CrossRef
  • Predictors of reoperation for perianal fistula in Crohn's disease
    Kwangwoo Nam, Won Beom Jung, Seung Bum Lee, Jae Seung Soh, Song Soo Yang, Seok Won Jung
    Journal of Digestive Diseases.2021; 22(6): 334.     CrossRef
  • Managing Complex Perianal Fistulizing Disease
    Karina E. Pedersen, Amy L. Lightner
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2021; 31(8): 890.     CrossRef
  • Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn’s disease treated with antitumor necrosis factor-alpha agents based on Parks’ classification
    Nahla Azzam, Othman Alharbi, Majid Almadi, Abdulrahman Aljebreen, Turki AlAmeel, Mohammed Alabbas, Salman Bahammam, Ahmed Bashmail, Yasser Alomar, Mahmoud Mosli
    European Journal of Gastroenterology & Hepatology.2020; 32(2): 187.     CrossRef
  • Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy
    Jihye Kim, Jong Pil Im, Jae-Joon Yim, Chang Kyun Lee, Dong Il Park, Chang Soo Eun, Sung-Ae Jung, Jeong Eun Shin, Kang-Moon Lee, Jae Hee Cheon
    The Korean Journal of Gastroenterology.2020; 75(1): 29.     CrossRef
  • Characteristics of biological therapy in pediatric patients with Crohn’s disease
    Andras Tarnok, Zoltan Kiss, Orsolya Kadenczki, Gabor Veres
    Expert Opinion on Biological Therapy.2019; 19(3): 181.     CrossRef
  • Endorectal Advancement Flaps for Perianal Fistulae in Crohn’s Disease: Careful Patient Selection Leads to Optimal Outcomes
    Michelle T. Roper, Stephen M. Trinidad, Sonia L. Ramamoorthy, Lisa A. Parry, Nicole E. Lopez, Sergey Khaitov, Randolph Steinhagen, Samuel G. Eisenstein
    Journal of Gastrointestinal Surgery.2019; 23(11): 2277.     CrossRef
  • Maneuvering Clinical Pathways for Crohn’s Disease
    Thomas X. Lu, Russell D. Cohen
    Current Gastroenterology Reports.2019;[Epub]     CrossRef
  • Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia
    Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chia
    Journal of Gastroenterology and Hepatology.2019; 34(8): 1296.     CrossRef
  • Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia
    Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chia
    Intestinal Research.2019; 17(3): 285.     CrossRef
  • Long‐term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first‐line biologics
    Toshihiro Inokuchi, Sakuma Takahashi, Sakiko Hiraoka, Tatsuya Toyokawa, Shinjiro Takagi, Koji Takemoto, Jiro Miyaike, Tsuyoshi Fujimoto, Reiji Higashi, Yuki Morito, Toru Nawa, Seiyuu Suzuki, Mamoru Nishimura, Masafumi Inoue, Jun Kato, Hiroyuki Okada
    Journal of Gastroenterology and Hepatology.2019; 34(8): 1329.     CrossRef
  • Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
    Jong Pil Im
    Intestinal Research.2017; 15(2): 147.     CrossRef
  • 5,233 View
  • 71 Download
  • 20 Web of Science
  • 23 Crossref
Close layer
Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
Suraj Kumar, Sawan Bopanna, Saurabh Kedia, Pratap Mouli, Rajan Dhingra, Rajesh Padhan, Mikashmi Kohli, Jigyasa Chaubey, Rohini Sharma, Prasenjit Das, S Dattagupta, Govind Makharia, SK Sharma, Vineet Ahuja
Intest Res 2017;15(2):187-194.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.187
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

The use of genetic probes for the diagnosis of pulmonary tuberculosis (TB) has been well described. However, the role of these assays in the diagnosis of intestinal tuberculosis is unclear. We therefore assessed the diagnostic utility of the Xpert Mycobacterium tuberculosis/rifampicin (MTB/RIF) assay, and estimated the prevalence of multidrug-resistant (MDR) TB in the Indian population.

Methods

Of 99 patients recruited, 37 had intestinal TB; two control groups comprised 43 with Crohn's disease (CD) and 19 with irritable bowel syndrome. Colonoscopy was performed before starting any therapy; mucosal biopsies were subjected to histopathology, acid-fast bacilli staining, Lowenstein-Jensen culture, and nucleic acid amplification testing using the Xpert MTB/RIF assay. Patients were followed up for 6 months to confirm the diagnosis and response to therapy. A composite reference standard was used for diagnosis of TB and assessment of the diagnostic utility of the Xpert MTB/RIF assay.

Results

Of 37 intestinal TB patients, the Xpert MTB/RIF assay was positive in three of 37 (8.1%), but none had MDR-TB. The sensitivity, specificity, positive predictive value, and negative predictive value of the Xpert MTB/RIF assay was 8.1%, 100%, 100%, and, 64.2%, respectively.

Conclusions

The Xpert MTB/RIF assay has low sensitivity but high specificity for intestinal TB, and may be helpful in endemic tuberculosis areas, when clinicians are faced with difficulty differentiating TB and CD. Based on the Xpert MTB/RIF assay, the prevalence of intestinal MDR-TB is low in the Indian population.

Citations

Citations to this article as recorded by  
  • Perfusion Computed Tomography May Help in Discriminating Gastrointestinal Tuberculosis and Crohn’s Disease
    Raghav Seth, Pankaj Gupta, Uma Debi, Kaushal Kishore Prasad, Harjeet Singh, Vishal Sharma
    Diagnostics.2023; 13(7): 1255.     CrossRef
  • Clinical characteristics and diagnosis of intestinal tuberculosis in clinical practice at Thailand’s largest national tertiary referral center: An 11-year retrospective review
    Asawin Sudcharoen, Gahwin Ruchikajorndech, Sitthipong Srisajjakul, Ananya Pongpaibul, Popchai Ngamskulrungroj, Orawan Tulyaprawat, Julajak Limsrivilai, Mao-Shui Wang
    PLOS ONE.2023; 18(4): e0282392.     CrossRef
  • Analytical performances of the Xpert MTB/RIF assay using stool specimens to improve the diagnosis of pulmonary tuberculosis in Burkina Faso, a tuberculosis endemic country
    Odilon D. Kaboré, Anselme Millogo, Bintou Sanogo, Emile Birba, Armel Poda, Boubacar Nacro, Olivier Marcy, Sylvain Godreuil, Abdoul-Salam Ouédraogo, Mao-Shui Wang
    PLOS ONE.2023; 18(7): e0288671.     CrossRef
  • Meta-analysis of diagnostic accuracy of nucleic acid amplification tests for abdominal tuberculosis
    Yanqin Shen, Likui Fang, Bo Ye, Guocan Yu, Kamal Kishore Chopra
    PLOS ONE.2023; 18(11): e0289336.     CrossRef
  • Chapitre 7: La tuberculose extrapulmonaire
    Leila Barss, William J. A. Connors, Dina Fisher
    Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.2023; 7(6): 365.     CrossRef
  • Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests
    Preeti Mor, Bhawna Dahiya, Sanjeev Parshad, Pooja Gulati, Promod K. Mehta
    Expert Review of Gastroenterology & Hepatology.2022; 16(1): 33.     CrossRef
  • Chapter 7: Extra-pulmonary tuberculosis
    Leila Barss, William J. A. Connors, Dina Fisher
    Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.2022; 6(sup1): 87.     CrossRef
  • Abdominal Tuberculosis Mimicking Ovarian Cancer: A Case Report and Review of the Literature
    Ikhwan Rinaldi, Abdul Muthalib, Djaja Gosal, Teguh Wijayadi, Barlian Sutedja, Tjondro Setiawan, Andika Gunawan, Nelly Susanto, Lingga Magdalena, Diah Rini Handjari, Fetisari Kurniawan, Aisyah Rifani, Kevin Winston
    International Medical Case Reports Journal.2022; Volume 15: 169.     CrossRef
  • Intestinal Tuberculosis Presenting with Gastrointestinal Bleeding in Patient on Warfarin Therapy
    Werimo Pascal Kuka, Joe Rakiro, Joseph Gatheru, Felix Riunga, Allan Rajula, Daniel C. Damin
    Case Reports in Gastrointestinal Medicine.2022; 2022: 1.     CrossRef
  • Evaluating diagnostic performance of Truenat MTB Plus for gastrointestinal tuberculosis
    Kusum Sharma, Megha Sharma, Vishal Sharma, Megha Sharma, Jayanta Samanta, Aman Sharma, Rakesh Kochhar, Saroj Kant Sinha
    Journal of Gastroenterology and Hepatology.2022; 37(8): 1571.     CrossRef
  • Totally laparoscopic treatment of intestinal tuberculosis complicated with bowel perforation: The first case report in worldwide literature with a brief review
    Giuseppe Di Buono, Roberta Vella, Giuseppe Amato, Giorgio Romano, Vito Rodolico, Marta Saverino, Giovanni De Lisi, Giorgio Romano, Salvatore Buscemi, Antonino Agrusa
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Acid fast bacillus smear, mycobacterial culture and Xpert MTB/RIF assay for the diagnosis of tuberculous peritonitis in patients with and without end stage renal failure
    Richa Misra, Mitra Kar, Samir Mohindra, Amit Gupta
    Access Microbiology .2022;[Epub]     CrossRef
  • Diagnostic accuracy of the Xpert MTB/RIF assay for abdominal tuberculosis: a systematic review and meta-analysis
    Vishal Sharma, Hariom Soni, Praveen Kumar-M, Saurabh Dawra, Shubhra Mishra, Harshal S Mandavdhare, Harjeet Singh, Usha Dutta
    Expert Review of Anti-infective Therapy.2021; 19(2): 253.     CrossRef
  • Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
    Mikashmi Kohli, Ian Schiller, Nandini Dendukuri, Mandy Yao, Keertan Dheda, Claudia M Denkinger, Samuel G Schumacher, Karen R Steingart
    Cochrane Database of Systematic Reviews.2021;[Epub]     CrossRef
  • Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion
    Saurabh Kedia, Vineet Ahuja
    JGH Open.2021; 5(2): 177.     CrossRef
  • Application value of tissue tuberculosis antigen combined with Xpert MTB/RIF detection in differential diagnoses of intestinal tuberculosis and Crohn’s disease
    Baoying Fei, Lin Zhou, Yu Zhang, Linhe Luo, Yuanyuan Chen
    BMC Infectious Diseases.2021;[Epub]     CrossRef
  • Gastrointestinal tuberculosis
    Adnan B. Al-Zanbagi, M. K. Shariff
    Saudi Journal of Gastroenterology.2021; 27(5): 261.     CrossRef
  • A combination of circulating microRNA-375-3p and chemokines CCL11, CXCL12, and G-CSF differentiate Crohn’s disease and intestinal tuberculosis
    Susree Roy, Suchandrima Ghosh, Mallica Banerjee, Sayantan Laha, Dipanjan Bhattacharjee, Rajib Sarkar, Sujay Ray, Arko Banerjee, Ranajoy Ghosh, Aniket Halder, Alakendu Ghosh, Raghunath Chatterjee, Simanti Datta, Gopal Krishna Dhali, Soma Banerjee
    Scientific Reports.2021;[Epub]     CrossRef
  • An Outcome-Based Composite Approach for the Diagnosis of Intestinal Tuberculosis: A Pilot Study from a Tertiary Care Centre in South India
    Roopa Rachel Paulose, V Anil Kumar, Aparna Sharma, Aditi Damle, Divya Saikumar, Abish Sudhakar, Anoop K Koshy, Rama P Venu
    Journal of the Royal College of Physicians of Edinburgh.2021; 51(4): 344.     CrossRef
  • Abdominal Tuberculosis in Children: Challenges, Uncertainty, and Confusion
    Giulia Sartoris, James A Seddon, Helena Rabie, Etienne D Nel, H Simon Schaaf
    Journal of the Pediatric Infectious Diseases Society.2020; 9(2): 218.     CrossRef
  • How can gastro-intestinal tuberculosis diagnosis be improved? A prospective cohort study
    Christopher Lowbridge, Soraya A. M. Fadhil, Gayathri D. Krishnan, Emma Schimann, Raman Muthu Karuppan, Nagaraj Sriram, Giri Shan Rajahram, Jayaram Menon, Aatish Patel, Timothy William, Dawn Carmel Paul, Anna P. Ralph
    BMC Infectious Diseases.2020;[Epub]     CrossRef
  • Abdominal Tuberculosis Mimicking Ovarian Cancer: A Diagnostic Dilemma
    Anitha Thomas, Ajit Sebastian, Rachel George, Dhanya Susan Thomas, Grace Rebekah, Priscila Rupali, Joy Sarojini Michael, Abraham Peedicayil
    The Journal of Obstetrics and Gynecology of India.2020; 70(4): 304.     CrossRef
  • Apoptosis in peripheral blood lymphocytes in intestinal tuberculosis and Crohn’s disease: Implications to diagnostic differentiation
    Suprabha Suresh Nayak, Mamatha Vishwanatha Shetty, Cannanore Ganesh Pai, Kanive Parashiva Guruprasad, Kapaettu Satyamoorthy
    Indian Journal of Gastroenterology.2020; 39(4): 338.     CrossRef
  • Multiplex Polymerase Chain Reaction for diagnosis of gastrointestinal tuberculosis
    Sarthak Malik, Kusum Sharma, Kim Vaiphei, Narendra Dhaka, Neha Berry, Pankaj Gupta, Megha Sharma, Bipadabhanjan Mallick, Rakesh Kochhar, Saroj K Sinha
    JGH Open.2019; 3(1): 32.     CrossRef
  • Differentiating Crohn’s disease from intestinal tuberculosis
    Saurabh Kedia, Prasenjit Das, Kumble Seetharama Madhusudhan, Siddhartha Dattagupta, Raju Sharma, Peush Sahni, Govind Makharia, Vineet Ahuja
    World Journal of Gastroenterology.2019; 25(4): 418.     CrossRef
  • Utility of tissue Xpert-Mtb/Rif for the diagnosis of intestinal tuberculosis in patients with ileocolonic ulcers
    Balaji L Bellam, Harshal S Mandavdhare, Kusum Sharma, Siddharth Shukla, Hariom Soni, Praveen Kumar-M, Harjeet Singh, Kaushal K Prasad, Usha Dutta, Vishal Sharma
    Therapeutic Advances in Infectious Disease.2019; 6: 204993611986393.     CrossRef
  • GeneXpert in stool: Diagnostic yield in Intestinal Tuberculosis
    Abu Talib, Shaheen Bhatty, Khalid Mehmood, Huda Naim, Iftikhar Haider, Hari Lal, Gohar Ali, Muhammad Nashit
    Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.2019; 17: 100131.     CrossRef
  • GENEXPERT FOR ABDOMINAL TUBERCULOSIS
    Alka SHARMA
    Arquivos de Gastroenterologia.2019; 56(4): 454.     CrossRef
  • A diagnostic approach for differentiating abdominal tuberculosis from ovarian malignancy: a case series and literature review
    Moh Nailul Fahmi, Annisaa Pelita Harti
    BMC Proceedings.2019;[Epub]     CrossRef
  • Xpert®MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
    Mikashmi Kohli, Ian Schiller, Nandini Dendukuri, Keertan Dheda, Claudia M Denkinger, Samuel G Schumacher, Karen R Steingart
    Cochrane Database of Systematic Reviews.2018;[Epub]     CrossRef
  • Surgery for Abdominal Tuberculosis in the Present Era: Experience from a Tertiary-Care Center
    Harjeet Singh, Gautham Krishnamurthy, Jayapal Rajendran, Vishal Sharma, Harshal Mandavdhare, Hemanth Kumar, Thakur Deen Yadav, Rakesh Kumar Vasishta, Rajinder Singh
    Surgical Infections.2018; 19(6): 640.     CrossRef
  • Making a Positive Diagnosis of Intestinal Tuberculosis with the Aid of New Biologic and Histologic Features: How Far Have We Reached?
    Vatsal Mehta, Devendra Desai, Philip Abraham, Camilla Rodrigues
    Inflammatory Intestinal Diseases.2018; 3(4): 155.     CrossRef
  • Editor’s Pick: Recent Advances in the Diagnosis and Management of Abdominal Tuberculosis
    Harshal S. Mandavdhare, Harjeet Singh, Vishal Sharma
    EMJ Gastroenterology.2017; : 52.     CrossRef
  • 6,368 View
  • 93 Download
  • 30 Web of Science
  • 33 Crossref
Close layer
Patients with computed tomography-proven acute diverticulitis require follow-up to exclude colorectal cancer
Shafquat Zaman, Warren Chapman, Imtiyaz Mohammed, Kathryn Gill, Stephen Thomas Ward
Intest Res 2017;15(2):195-202.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.195
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Traditionally, patients with acute diverticulitis undergo follow-up endoscopy to exclude colorectal cancer (CRC). However, its usefulness has been debated in this era of high-resolution computed tomography (CT) diagnosis. We assessed the frequency and outcome of endoscopic follow-up for patients with CT-proven acute diverticulitis, according to the confidence in the CT diagnosis.

Methods

Records of patients with CT-proven acute diverticulitis between October 2007 and March 2014 at Sandwell & West Birmingham Hospitals NHS Trust were retrieved. The National Cancer Registry confirmed the cases of CRC. Endoscopy quality indicators were compared between these patients and other patients undergoing the same endoscopic examination over the same period.

Results

We identified 235 patients with CT-proven acute diverticulitis, of which, 187 were managed conservatively. The CT report was confident of the diagnosis of acute diverticulitis in 75% cases. Five of the 235 patients were subsequently diagnosed with CRC (2.1%). Three cases of CRC were detected in the 187 patients managed conservatively (1.6%). Forty-eight percent of the conservatively managed patients underwent follow-up endoscopy; one case of CRC was identified. Endoscopies were often incomplete and caused more discomfort for patients with diverticulitis compared with controls.

Conclusions

CRC was diagnosed in patients with CT-proven diverticulitis at a higher rate than in screened asymptomatic populations, necessitating follow-up. CT reports contained statements regarding diagnostic uncertainty in 25% cases, associated with an increased risk of CRC. Follow-up endoscopy in patients with CT-proven diverticulitis is associated with increased discomfort and high rates of incompletion. The use of other follow-up modalities should be considered.

Citations

Citations to this article as recorded by  
  • Endoscopic findings after CT proven acute diverticulitis: a systematic review and meta‐analysis
    Amy Millicent Yesheng Cao, Vincent Wai Lam, Matthew John Francis Xavier Rickard
    ANZ Journal of Surgery.2023; 93(5): 1150.     CrossRef
  • Comparison of colonoscopy after colonic diverticulitis and positive fecal immunochemical tests for the detection of colorectal neoplasia
    Dai Nakamatsu, Tsutomu Nishida, Shinji Kuriki, Li-sa Chang, Kazuki Aochi, Emi Meren, Tatsuya Sakamoto, Ryo Tomita, Yu Higaki, Naoto Osugi, Aya Sugimoto, Kei Takahashi, Kaori Mukai, Kengo Matsumoto, Shiro Hayashi, Sachiko Nakajima, Masashi Yamamoto, Koji F
    Endoscopy International Open.2021; 09(03): E331.     CrossRef
  • Imaging Modalities for Evaluation of Intestinal Obstruction
    David W. Nelms, Brian R. Kann
    Clinics in Colon and Rectal Surgery.2021; 34(04): 205.     CrossRef
  • Computed Tomography of Common Bowel Emergencies
    Kishan Patel, Nanxi Zha, Shana Neumann, Mitiadis Nicholas Tembelis, Mario Juliano, Naziya Samreen, Jawad Hussain, Mariam Moshiri, Michael N. Patlas, Douglas S. Katz
    Seminars in Roentgenology.2020; 55(2): 150.     CrossRef
  • Short‐ and Long‐Term Outcomes of Right‐Sided Diverticulitis: Over 15 Years of North American Experience
    Jesse Zuckerman, Richard Garfinkle, Carol‐Ann Vasilevksy, Gabriela Ghitulescu, Julio Faria, Nancy Morin, Marylise Boutros
    World Journal of Surgery.2020; 44(6): 1994.     CrossRef
  • Diverticulitis: An Update From the Age Old Paradigm
    Alexander T. Hawkins, Paul E. Wise, Tiffany Chan, Janet T. Lee, Tamara Glyn, Verity Wood, Timothy Eglinton, Frank Frizelle, Adil Khan, Jason Hall, M.I. Mohammed Ilyas, Maria Michailidou, Valentine N. Nfonsam, Michelle L. Cowan, Jennifer Williams, Scott R.
    Current Problems in Surgery.2020; 57(10): 100862.     CrossRef
  • Duodenal Diverticulosis as an Unusual Cause of Severe Abdominal Pain
    Wajd A Aljabri, Mohammed Hasosah, Abeer AlMehdar, Dohaa Bakhsh, Faris O Alturkistany
    Cureus.2020;[Epub]     CrossRef
  • CT colonography: implementation, indications, and technical performance – a follow-up national survey
    Fredrik Thorén, Åse A Johnsson, John Brandberg, Mikael Hellström
    Acta Radiologica.2019; 60(3): 271.     CrossRef
  • Risk of Colorectal Cancer in Patients With Acute Diverticulitis: A Systematic Review and Meta-analysis of Observational Studies
    Jeremy Meyer, Lorenzo A. Orci, Christophe Combescure, Alexandre Balaphas, Philippe Morel, Nicolas C. Buchs, Frédéric Ris
    Clinical Gastroenterology and Hepatology.2019; 17(8): 1448.     CrossRef
  • Meta-analysis of the role of colonoscopy after an episode of left-sided acute diverticulitis
    S J Rottier, S T Dijk, A A W Geloven, W H Schreurs, W A Draaisma, W A Enst, J B C M Puylaert, M G J Boer, B R Klarenbeek, J A Otte, R J F Felt, M A Boermeester
    British Journal of Surgery.2019; 106(8): 988.     CrossRef
  • 5,085 View
  • 48 Download
  • 10 Web of Science
  • 10 Crossref
Close layer
Red flag symptoms: detailed account of clinicopathological features in young-onset colorectal cancer
Ramish Riaz, Nosheen Masood, Arfa Benish
Intest Res 2017;15(2):203-207.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.203
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Colorectal cancer has long been considered disease of the West, typically occurring in old age; however, the incidence is rising in Asia. The pattern of disease is quite different in Asia, occurring at a younger age and at an advanced stage. Recognition of disease at an early stage is still a challenge for physicians. Few data are available regarding young-onset colorectal cancer in Pakistan. We conducted this study to fill this gap and provide deeper insight into clinical symptoms and histopathological features of young-onset colorectal cancer.

Methods

We collected data regarding clinical features by directly interviewing patients and obtaining histopathological data from hospital records. Patients aged less than 50 years were included in the study. Statistical analysis was performed using IBM SPSS version 20.0.

Results

Results in 105 patients showed mean age at diagnosis was 35.90±9.39, with male predominance; the majority of patients had no family history of colorectal cancer. Most patients had left-sided tumors with advance stage and intermediate grade (grade 2). Mucinous histology was common. Rectal bleeding was the first symptom for left-sided tumors, whereas most of the right-sided lesions presented with sudden obstruction.

Conclusions

Painless rectal bleeding in the early thirties should alert physicians to advise appropriate investigation, as the majority of young-onset colorectal cancer patients develop painless bleeding 2 to 3 years before appearance of other symptoms.

Citations

Citations to this article as recorded by  
  • Comparison of clinical features and prognosis of early- and late-onset colorectal cancer
    Xian Long, Yue Wang, Zi-Qing Jian, Qiong He
    World Chinese Journal of Digestology.2024; 32(2): 116.     CrossRef
  • Symptom Burden and Time from Symptom Onset to Cancer Diagnosis in Patients with Early-Onset Colorectal Cancer: A Multicenter Retrospective Analysis
    Victoria A. Baronas, Arif A. Arif, Eric Bhang, Gale K. Ladua, Carl J. Brown, Fergal Donnellan, Sharlene Gill, Heather C. Stuart, Jonathan M. Loree
    Current Oncology.2024; 31(4): 2133.     CrossRef
  • Multimodal Treatment of Metastatic Rectal Cancer in a Young Patient: Case Report and Literature Review
    Ionuț Popescu, Ana-Maria Dudău, Simona Dima, Vlad Herlea, Vlad M. Croitoru, Ioana Mihaela Dinu, Monica Miron, Ioana Lupescu, Irina M. Croitoru-Cazacu, Radu Dumitru, Adina Emilia Croitoru
    Medicina.2024; 60(5): 696.     CrossRef
  • Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer
    Joshua Demb, Jennifer M. Kolb, Jonathan Dounel, Cassandra D. L. Fritz, Shailesh M. Advani, Yin Cao, Penny Coppernoll-Blach, Andrea J. Dwyer, Jose Perea, Karen M. Heskett, Andreana N. Holowatyj, Christopher H. Lieu, Siddharth Singh, Manon C. W. Spaander, F
    JAMA Network Open.2024; 7(5): e2413157.     CrossRef
  • Clinicopathological features and short-term surgical outcomes of early-onset versus late-onset colorectal cancer at a tertiary hospital in Tanzania: A retrospective-cohort study
    George Kanani, Samwel Byabato, Jasmine Mrisho, Vihar Kotecha, Yasin Munis, Felician Kachinde, Ahmed Binde
    Surgical Oncology Insight.2024; 1(3): 100061.     CrossRef
  • Oncotherapeutic Strategies in Early Onset Colorectal Cancer
    Mary O’Reilly, Anna Linehan, Aleksandar Krstic, Walter Kolch, Kieran Sheahan, Des C. Winter, Ray Mc Dermott
    Cancers.2023; 15(2): 552.     CrossRef
  • Characteristics and symptomatology of colorectal cancer in the young
    Mary Kate Skalitzky, Peige P. Zhou, Paolo Goffredo, Kristina Guyton, Scott K. Sherman, Irena Gribovskaja-Rupp, Imran Hassan, Muneera R. Kapadia, Jennifer E. Hrabe
    Surgery.2023; 173(5): 1137.     CrossRef
  • Early-onset colorectal cancer: A review of current knowledge
    Margarida R Saraiva, Isadora Rosa, Isabel Claro
    World Journal of Gastroenterology.2023; 29(8): 1289.     CrossRef
  • Sulfur Metabolism of the Gut Microbiome and Colorectal Cancer: The Threat to the Younger Generation
    Ji-Yeon Moon, Bong-Hyeon Kye, Seung-Hyun Ko, Ri Na Yoo
    Nutrients.2023; 15(8): 1966.     CrossRef
  • Early-Onset Colorectal Cancer: Current Insights
    Fauzia Ullah, Ashwathy Balachandran Pillai, Najiullah Omar, Danai Dima, Seema Harichand
    Cancers.2023; 15(12): 3202.     CrossRef
  • Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition
    Bianca Medici, Beatrice Riccò, Eugenia Caffari, Silvia Zaniboni, Massimiliano Salati, Andrea Spallanzani, Ingrid Garajovà, Stefania Benatti, Chiara Chiavelli, Massimo Dominici, Fabio Gelsomino
    Cancers.2023; 15(13): 3509.     CrossRef
  • The analysis between clinicopathological aspect of early-onset vs. late-onset colorectal cancer and mortality rate: a cross-sectional study
    Kiki Lukman, Andi Mulyawan, Annisa Dewi Nugrahani, Reno Rudiman, Etis Primastari
    Annals of Medicine & Surgery.2023; 85(6): 2496.     CrossRef
  • The role of colonoscopy in young patients with rectal bleeding: a systematic review and meta-analysis
    Tuane Colles, Patrícia K. Ziegelmann, Daniel C. Damin
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • A comprehensive framework for early-onset colorectal cancer research
    Cathy Eng, Alexandre A Jácome, Rajiv Agarwal, Muhammad Hashim Hayat, Mariana X Byndloss, Andreana N Holowatyj, Christina Bailey, Christopher H Lieu
    The Lancet Oncology.2022; 23(3): e116.     CrossRef
  • Strengthening Breast Cancer Screening Mammography Services in Pakistan Using Islamabad Capital Territory as a Pilot Public Health Intervention
    Ayesha Isani Majeed, Assad Hafeez, Shahzad Ali Khan
    Healthcare.2022; 10(6): 1106.     CrossRef
  • Young-onset colorectal cancer risk among individuals with iron-deficiency anaemia and haematochezia
    Joshua Demb, Lin Liu, Caitlin C. Murphy, Chyke A. Doubeni, María Elena Martínez, Samir Gupta
    Gut.2021; 70(8): 1529.     CrossRef
  • Is colorectal cancer associated with altered bowel habits in young patients?
    Ashray Rajagopalan, Ellathios Antoniou, Marina Morkos, Ellen Rajagopalan, Asiri Arachchi, Hanumant Chouhan, Thang Chien Nguyen, William Teoh
    ANZ Journal of Surgery.2021; 91(5): 943.     CrossRef
  • Why is colorectal cancer increasing in younger age groups in the United States?
    Obaida Dairi, Joseph C. Anderson, Lynn F. Butterly
    Expert Review of Gastroenterology & Hepatology.2021; 15(6): 623.     CrossRef
  • The Time to Act Is Now: The Rationale to Start Colorectal Cancer Screening at Age 45
    Peter M. Fields, Joseph C. Anderson, Stacey A. Fedewa
    Current Treatment Options in Gastroenterology.2021; 19(3): 421.     CrossRef
  • Assessing Presenting Symptoms, Co-Morbidities, and Risk Factors for Mortality in Underserved Patients With Non-Hereditary Early-Onset Colorectal Cancer
    Shravani Reddy, Awf Mouchli, Lindsey Bierle, Miranda Gerrard, Chirstopher Walsh, Adil Mir, David P Lebel, Christopher Mason, Douglas Grider, Marrieth Rubio
    Cureus.2021;[Epub]     CrossRef
  • Colorectal cancer patients in a tertiary hospital in Indonesia: Prevalence of the younger population and associated factors
    Dadang Makmun, Marcellus Simadibrata, Murdani Abdullah, Ari F Syam, Hamzah Shatri, Achmad Fauzi, Kaka Renaldi, Hasan Maulahela, Amanda P Utari, Rabbinu R Pribadi, Virly N Muzellina, Saskia A Nursyirwan
    World Journal of Clinical Cases.2021; 9(32): 9804.     CrossRef
  • Obscure Gastrointestinal Bleeding Due to Colonic Source
    Robert W. Klapheke, Ethan Bortniker
    Current Treatment Options in Gastroenterology.2020; 18(3): 394.     CrossRef
  • AGA Clinical Practice Update on Young Adult–Onset Colorectal Cancer Diagnosis and Management: Expert Review
    Lisa A. Boardman, Eduardo Vilar, Y. Nancy You, Jewel Samadder
    Clinical Gastroenterology and Hepatology.2020; 18(11): 2415.     CrossRef
  • Age at menarche and risk of colorectal adenoma
    Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    The Korean Journal of Internal Medicine.2019; 34(5): 998.     CrossRef
  • Early‐onset colorectal cancer in young individuals
    Gianluca Mauri, Andrea Sartore‐Bianchi, Antonio‐Giampiero Russo, Silvia Marsoni, Alberto Bardelli, Salvatore Siena
    Molecular Oncology.2019; 13(2): 109.     CrossRef
  • Colorectal Cancer in Young Adults
    Anand Venugopal, Elena M. Stoffel
    Current Treatment Options in Gastroenterology.2019; 17(1): 89.     CrossRef
  • Analysis of population‐based colorectal cancer screening in Guangzhou, 2011‐2015
    Feng Zhiqiang, Cao Jie, Nie Yuqiang, Gong Chenghua, Wang Hong, Sun Zheng, Li Wanglin, Zhou Yongjian, Dai Liping, Zeng Lizhong, Zhao DeJian
    Cancer Medicine.2019; 8(5): 2496.     CrossRef
  • Optimal Starting Age for Colorectal Cancer Screening in an Era of Increased Metabolic Unhealthiness: A Nationwide Korean Cross-Sectional Study
    Yoon Jin Choi, Dong Ho Lee, Kyung-Do Han, Hyun Soo Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim
    Gut and Liver.2018; 12(6): 655.     CrossRef
  • Is colorectal cancer screening necessary before 50 years of age?
    Yoon Suk Jung
    Intestinal Research.2017; 15(4): 550.     CrossRef
  • 6,625 View
  • 86 Download
  • 27 Web of Science
  • 29 Crossref
Close layer
Diagnostic and prognostic value of preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography for colorectal cancer: comparison with conventional computed tomography
Joo Young Lee, Soon Man Yoon, Jeong Tae Kim, Ki Bae Kim, Mi Jin Kim, Jae Geun Park, Taek-Gu Lee, Sang-Jeon Lee, Sung Soo Koong, Joung-Ho Han, Hee Bok Chae, Seon Mee Park, Sei Jin Youn
Intest Res 2017;15(2):208-214.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.208
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) has been used for preoperative staging of colorectal cancer (CRC). However, the diagnostic accuracy of FDG-PET/CT for detection of lymph node or distant metastasis and its prognostic role have not been well established. We therefore evaluated the diagnostic and prognostic value of FDG-PET/CT in comparison with conventional CT for CRC.

Methods

We investigated 220 patients who underwent preoperative FDG-PET/CT and CT, followed by curative surgery for CRC. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of FDG-PET/CT and CT for detection of lymph node metastasis and distant metastasis were evaluated. In addition, we assessed the findings of FDG-PET/CT and CT according to outcomes, including cancer recurrence and cancer-related death, for evaluation of prognostic value.

Results

For detection of lymph node metastasis, FDG-PET/CT had a sensitivity of 44%, a specificity of 84%, and an accuracy of 67%, compared with 59%, 65%, and 62%, respectively, for CT (P=0.029, P=0.000, and P=0.022). For distant metastasis, FDG-PET/CT had a sensitivity of 79%, a specificity of 94%, and an accuracy of 93%, compared with 79%, 87%, and 86%, respectively, for CT (P=1.000, P=0.004, and P=0.037). In addition, positive findings of lymph node metastasis and distant metastasis on FDG-PET/CT were associated significantly with cancer recurrence or cancer-related death (P=0.009, P=0.001, respectively).

Conclusions

Preoperative FDG-PET/CT had a higher specificity and accuracy compared to CT for detection of lymph node metastasis and distant metastasis of CRC. In addition, FDG-PET/CT could be a valuable prognostic tool for CRC.

Citations

Citations to this article as recorded by  
  • Retrospective audit: Utility of PET scan in routine preoperative rectal cancer staging
    Michelle Zhiyun Chen, Xinyi Zhang, Milton Mui, Joseph C. H. Kong, Alexander G. Heriot, Jodie Ellis‐Clark
    ANZ Journal of Surgery.2023; 93(3): 617.     CrossRef
  • Impact of routine preoperative 18FDG PET/CT on the surgical management of primary colorectal cancer
    Mónica Mogollón‐González, Raquel Conde‐Muiño, Antonio Rodríguez‐Fernández, Mar Navarro‐Pelayo, Mireia Domínguez‐Bastante, Pablo Palma
    Journal of Surgical Oncology.2023; 128(2): 295.     CrossRef
  • Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience
    Hui Tan, Danjie Cai, Xiuli Sui, Chi Qi, Wujian Mao, Yiqiu Zhang, Guobing Liu, Haojun Yu, Shuguang Chen, Pengcheng Hu, Jianying Gu, Hongcheng Shi
    European Journal of Nuclear Medicine and Molecular Imaging.2022; 49(3): 1002.     CrossRef
  • Tailoring the clinical management of colorectal cancer by 18F-FDG PET/CT
    Yang Shi, Meiqi Wang, Jiyu Zhang, Zheng Xiang, Can Li, Jingjing Zhang, Xing Ma
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature
    Hideaki Shimada, Takeo Fukagawa, Yoshio Haga, Shin‐ichi Okazumi, Koji Oba
    Annals of Gastroenterological Surgery.2021; 5(4): 404.     CrossRef
  • The significant value of predicting prognosis in patients with colorectal cancer using 18F-FDG PET metabolic parameters of primary tumors and hematological parameters
    Junyan Xu, Yi Li, Silong Hu, Linjun Lu, Zhiqi Gao, Huiyu Yuan
    Annals of Nuclear Medicine.2019; 33(1): 32.     CrossRef
  • Optimal Interval for 18F-FDG-PET After Chemoradiotherapy for Rectal Cancer
    Kazushige Kawai, Hiroaki Nozawa, Keisuke Hata, Toshiaki Tanaka, Takeshi Nishikawa, Koji Oba, Toshiaki Watanabe
    Clinical Colorectal Cancer.2018; 17(2): e163.     CrossRef
  • Preoperative PET/CT 18F-FDG Standardized Uptake by Lymph Nodes as a Significant Prognostic Factor in Patients with Colorectal Cancer
    Ruohua Chen, Yining Wang, Xiang Zhou, Gang Huang, Jianjun Liu
    Contrast Media & Molecular Imaging.2018; 2018: 1.     CrossRef
  • 5,760 View
  • 61 Download
  • 10 Web of Science
  • 8 Crossref
Close layer
Clinical outcomes of sigmoid colon volvulus: identification of the factors associated with successful endoscopic detorsion
Tomoya Iida, Suguru Nakagaki, Shuji Satoh, Haruo Shimizu, Hiroyuki Kaneto, Hiroshi Nakase
Intest Res 2017;15(2):215-220.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.215
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Although multiple treatment options exist for the management of sigmoid colon volvulus, no study has examined the factors associated with successful endoscopic detorsion. This study aimed to examine the clinical course of patients with sigmoid colon volvulus and to identify factors related to successful endoscopic detorsion.

Methods

This study included 30 cases (21 patients) of sigmoid volvulus from among 545 cases of intestinal obstruction at a single center. We retrospectively examined the clinical course and the factors associated with the possibility of endoscopic detorsion of sigmoid colon volvulus.

Results

The rate of laxative use among the study participants was 76.2%; the rate of comorbid neuropsychiatric disorders was 61.9%; and 57.1% of patients had a history of open abdominal surgery. All patients were initially treated with endoscopic detorsion, and this procedure had a 61.9% success rate. The recurrence rate after detorsion was as high as 46.2%, but detorsion during revision endoscopy was possible in all cases. Statistical analysis revealed that the absence of abdominal tenderness (P=0.027), the use of laxatives (P=0.027), and a history of open abdominal surgery (P=0.032) were factors predictive of successful endoscopic detorsion.

Conclusions

The results of our study are consistent with previous reports with respect to the success rate of endoscopic detorsion, the subsequent recurrence rate, and the proportion of patients requiring surgical treatment. In addition, we identified the absence of abdominal tenderness, the use of laxatives, and history of open abdominal surgery as factors predicting successful endoscopic detorsion of sigmoid colon volvulus.

Citations

Citations to this article as recorded by  
  • Clinical outcome of patients treated with endoscopic decompression after failure of detorsion for uncomplicated sigmoid volvulus
    Dai Nakamatsu, Tsutomu Nishida, Aya Sugimoto, Kengo Matsumoto, Masashi Yamamoto
    DEN Open.2024;[Epub]     CrossRef
  • Comments on “Percutaneous Endoscopic Sigmoidopexy: Still a Way to Go”
    Sabri Selcuk Atamanalp
    GE - Portuguese Journal of Gastroenterology.2024; 31(3): 151.     CrossRef
  • Dependent functional status is an independent risk factor for 30-day mortality and morbidities following colectomy for volvulus: An ACS-NSQIP study from the United States
    Renxi Li
    Clinics and Research in Hepatology and Gastroenterology.2024; 48(7): 102391.     CrossRef
  • Sigmoid volvulus as a rare cause of intestinal obstruction in the pediatric population: case series and literature review
    Isabel C. Brito Rojas, Mayra A. Hernández Peñuela, Vanessa Medina Gaviria, Martin La Rotta, John M. Escobar Echeverri
    International Journal of Surgery Open.2024; 62(2): 149.     CrossRef
  • Endoscopic Decompression of Sigmoid Volvulus: Review of 748 Patients
    Sabri Selcuk Atamanalp
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2022; 32(7): 763.     CrossRef
  • Initial Computed Tomography Findings of Long and Distended Colon Are Risk Factors for the Recurrence of Sigmoid Volvulus
    Ryusaku Kusunoki, Hirofumi Fujishiro, Tatsuya Miyake, Shinsuke Suemitsu, Masatoshi Kataoka, Aya Fujiwara, Kosuke Tsukano, Satoshi Kotani, Satoshi Yamanouchi, Masahito Aimi, Masaki Tanaka, Youichi Miyaoka, Naruaki Kohge, Tomonori Imaoka, Kouji Yuasa, Kouji
    Digestive Diseases and Sciences.2021; 66(4): 1162.     CrossRef
  • Risk factors affecting failure of colonoscopic detorsion for sigmoid colon volvulus: a single center experience
    Ahmet Surek, Cevher Akarsu, Eyup Gemici, Sina Ferahman, Ahmet Cem Dural, Mehmet Abdussamet Bozkurt, Turgut Donmez, Mehmet Karabulut, Halil Alis
    International Journal of Colorectal Disease.2021; 36(6): 1221.     CrossRef
  • The Association of Coloproctology of Great Britain and Ireland consensus guidelines in emergency colorectal surgery
    Andrew S. Miller, Kathryn Boyce, Benjamin Box, Matthew D. Clarke, Sarah E. Duff, Niamh M. Foley, Richard J. Guy, Lisa H. Massey, George Ramsay, Dominic A. J. Slade, James A. Stephenson, Phil J. Tozer, Danette Wright
    Colorectal Disease.2021; 23(2): 476.     CrossRef
  • Endoscopic Detorsion for Early Postoperative Roux Limb Torsion after Laparoscopic Gastrectomy: A Case Report and Literature Review
    Nobuyuki Sakurazawa, Hiroki Arai, Tomohiko Yasuda, Komei Kuge, Shou Kuriyama, Hideyuki Suzuki, Hiroshi Yoshida
    Journal of Nippon Medical School.2021; 88(6): 544.     CrossRef
  • Perioperative Outcomes and Predictors of Mortality After Surgery for Sigmoid Volvulus
    Anthony Easterday, Sarah Aurit, Rebecca Driessen, Austin Person, Devi Mukkai Krishnamurty
    Journal of Surgical Research.2020; 245: 119.     CrossRef
  • American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of acute colonic pseudo-obstruction and colonic volvulus
    Mariam Naveed, Laith H. Jamil, Larissa L. Fujii-Lau, Mohammad Al-Haddad, James L. Buxbaum, Douglas S. Fishman, Terry L. Jue, Joanna K. Law, Jeffrey K. Lee, Bashar J. Qumseya, Mandeep S. Sawhney, Nirav Thosani, Andrew C. Storm, Audrey H. Calderwood, Mouen
    Gastrointestinal Endoscopy.2020; 91(2): 228.     CrossRef
  • Endoscopic Decompression of Recurrent Sigmoid Volvulus in Pregnancy
    Nathaly Cortez, Manuel Berzosa, Kiranmayi Muddasani, Kfir Ben-David
    Journal of Investigative Medicine High Impact Case Reports.2020; 8: 232470962097593.     CrossRef
  • Endoscopic Management of Sigmoid Volvulus in a Debilitated Population: What Relevance?
    Manuel Coelho da Rocha, Tiago Capela, Mário Jorge Silva, Gonçalo Ramos, João Coimbra
    GE - Portuguese Journal of Gastroenterology.2020; 27(3): 160.     CrossRef
  • Author's Reply
    Tomoya Iida, Hiroyuki Kaneto, Hiroshi Nakase
    Intestinal Research.2017; 15(4): 554.     CrossRef
  • Comments on clinical outcomes of sigmoid colon volvulus: identification of the factors associated with successful endoscopic detorsion
    Sabri Selcuk Atamanalp
    Intestinal Research.2017; 15(4): 552.     CrossRef
  • 6,726 View
  • 93 Download
  • 20 Web of Science
  • 15 Crossref
Close layer
Clinical outcome of endoscopic management in delayed postpolypectomy bleeding
Jeong-Mi Lee, Wan Soo Kim, Min Seob Kwak, Sung-Wook Hwang, Dong-Hoon Yang, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
Intest Res 2017;15(2):221-227.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.221
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

The clinical course after endoscopic management of delayed postpolypectomy bleeding (DPPB) has not been clearly determined. This study aimed to assess clinical outcomes after endoscopic hemostasis of DPPB and evaluate risk factors for rebleeding after initial hemostasis.

Methods

We reviewed medical records of 198 patients who developed DPPB and underwent endoscopic hemostasis between January 2010 and February 2015. The performance of endoscopic hemostasis was assessed. Rebleeding negative and positive patients were compared.

Results

DPPB developed 1.4±1.6 days after colonoscopic polypectomy. All patients achieved initial hemostasis. Clipping was the most commonly used technique. Of 198 DPPB patients, 15 (7.6%) had rebleeding 3.3±2.5 days after initial hemostasis. The number of clips required for hemostasis was higher in the rebleeding positive group (3.2±1.6 vs. 4.2±1.9, P=0.047). Combinations of clipping with other modalities such as injection methods were more common in the rebleeding positive group (67/291, 23.0% vs. 12/17, 70.6%; P<0.001). Multivariate analysis showed a large number of clips and combination therapy were independent risk factors for rebleeding. All the rebleeding cases were successfully managed by repeat endoscopic hemostasis.

Conclusions

Endoscopic hemostasis is effective for the management of DPPB because of its high initial hemostasis rate and low rebleeding rate. Endoscopists should carefully observe patients in whom a large number of clips and/or combination therapy have been used to manage DPPB because these may be related to the severity of DPPB and a higher risk of rebleeding.

Citations

Citations to this article as recorded by  
  • Updates on the Prevention and Management of Post-Polypectomy Bleeding in the Colon
    Hisham Wehbe, Aditya Gutta, Mark A. Gromski
    Gastrointestinal Endoscopy Clinics of North America.2024; 34(2): 363.     CrossRef
  • The Use of Clips to Prevent Post-Polypectomy Bleeding: A Clinical Review
    Matthew A. O’Mara, Peter G. Emanuel, Aaron Tabibzadeh, Robert J. Duve, Jonathan S. Galati, Gregory Laynor, Samantha Gross, Seth A. Gross
    Journal of Clinical Gastroenterology.2024; 58(8): 739.     CrossRef
  • Endoscopic management of delayed bleeding after polypectomy of small colorectal polyps: two or more clips may be safe
    Xue-Feng Guo, Xiang-An Yu, Jian-Cong Hu, De-Zheng Lin, Jia-Xin Deng, Ming-Li Su, Juan Li, Wei Liu, Jia-Wei Zhang, Qing-Hua Zhong
    Gastroenterology Report.2022;[Epub]     CrossRef
  • Management and Outcomes of Bleeding Within 30 Days of Colonic Polypectomy in a Large, Real-Life, Multicenter Cohort Study
    Enrique Rodríguez de Santiago, Maria Hernández-Tejero, Liseth Rivero-Sánchez, Oswaldo Ortiz, Irene García de la Filia-Molina, Jose Ramon Foruny-Olcina, Hector Miguel Marcos Prieto, Maria García-Prada, Almudena González-Cotorruelo, Miguel Angel De Jorge Tu
    Clinical Gastroenterology and Hepatology.2021; 19(4): 732.     CrossRef
  • Clinical Features of Re-Colonoscopy after Bleeding after Intestinal Polypectomy
    慧敏 翟
    Advances in Clinical Medicine.2021; 11(11): 5151.     CrossRef
  • Systematic literature review of learning curves for colorectal polyp resection techniques in lower gastrointestinal endoscopy
    A. Rajendran, S. Pannick, S. Thomas‐Gibson, S. Oke, C. Anele, N. Sevdalis, A. Haycock
    Colorectal Disease.2020; 22(9): 1085.     CrossRef
  • Child-Pugh B or C Cirrhosis Increases the Risk for Bleeding Following Colonoscopic Polypectomy
    Hosim Soh, Jaeyoung Chun, Seung Wook Hong, Seona Park, Yun Bin Lee, Hyun Jung Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jong Pil Im, Yoon Jun Kim, Joo Sung Kim, Jung-Hwan Yoon
    Gut and Liver.2020; 14(6): 755.     CrossRef
  • Post-polypectomy Visible Vessel
    Matthew Woo, Robert Bechara
    Journal of the Canadian Association of Gastroenterology.2018; 1(2): 51.     CrossRef
  • Comprehensive review of outcomes of endoscopic treatment of gastrointestinal bleeding
    Tae-Geun Gweon, Jinsu Kim
    International Journal of Gastrointestinal Intervention.2018; 7(3): 123.     CrossRef
  • 5,014 View
  • 68 Download
  • 7 Web of Science
  • 9 Crossref
Close layer
Current practices in endoscopic submucosal dissection for colorectal neoplasms: a survey of indications among Korean endoscopists
Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Young-Ho Kim, Dong Kyung Chang
Intest Res 2017;15(2):228-235.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.228
AbstractAbstract PDFSupplementary MaterialPubReaderePub
<b>Background/Aims</b><br/>

The indications for colorectal endoscopic submucosal dissection (ESD) vary in clinical practice. To establish colorectal ESD as a standard treatment, standard indications are essential. For establishing standard indications for colorectal ESD, we surveyed the preferences and criteria of endoscopists for colorectal ESD in their practices.

Methods

A multiple-choice questionnaire was sent to 27 members of the Korean Society of Gastrointestinal Endoscopy/ESD group. The indications of endoscopists for selecting ESD as a treatment for colorectal tumors ≥2 cm in diameter were surveyed.

Results

On the basis of the preprocedural assessment of histology, adenoma with high-grade dysplasia, mucosal cancer, and shallow submucosa invasive cancer were included in the indication for ESD. Based on gross morphology, laterally spreading tumor (LST) granular nodular mixed type, LST-nongranular (LST-NG) flat elevated type, and LST-NG pseudodepressed type were included. On the basis of the pit pattern by Kudo classification, types III, IV, and V-I were included. Based on the narrow band imaging pattern by Sano classification, types II and III-a were included. Other lesions, such as sporadic localized tumors in chronic inflammation and local residual early carcinoma after endoscopic resection, were also included in the indication for ESD.

Conclusions

The indications of Korean endoscopists for colorectal ESD are broader than those in recent guidelines, and tend to include more benign-looking tumors. To find the appropriate indications for colorectal ESD, systematic data collection and analysis are required to reach a consensus in a timely manner.

Citations

Citations to this article as recorded by  
  • Long-term prognosis of curative endoscopic submucosal dissection for early colorectal cancer according to submucosal invasion: a multicenter cohort study
    Jongbeom Shin, Eun Ran Kim, Hyun Joo Jang, Dong Hoon Baek, Dong-Hoon Yang, Bo-In Lee, Kwang Bum Cho, Jin Woong Cho, Sung-Ae Jung, Su Jin Hong, Bong Min Ko, Jung-Won Jeon, Weon Jin Ko, Sun Moon Kim, Young Dae Kim, Kim Chan Gyoo, Gwang Ho Baik, In Kyung Yoo
    BMC Gastroenterology.2022;[Epub]     CrossRef
  • Risk of Covert Submucosal Cancer in Patients With Granular Mixed Laterally Spreading Tumors
    Ferdinando D’Amico, Arnaldo Amato, Andrea Iannone, Cristina Trovato, Chiara Romana, Stefano Angeletti, Roberta Maselli, Franco Radaelli, Giancarla Fiori, Edi Viale, Emilio Di Giulio, Paola Soriani, Mauro Manno, Emanuele Rondonotti, Piera Alessia Galtieri,
    Clinical Gastroenterology and Hepatology.2021; 19(7): 1395.     CrossRef
  • Clinical practice guideline for endoscopic resection of early gastrointestinal cancer
    Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, Jie-Hyun Kim, Ji Hyun Kim, Yang Won Min, Si Hyung Lee, Jung Ho Bae, Hyunsoo Chung, Kee Don Choi, Jun Chul Park, Hyuk Lee, Min-Seob Kwak, Bun Kim, Hyun Jung Lee, Hye Seung Lee, Miyoung Choi, Dong-Ah Park, Jong
    Intestinal Research.2021; 19(2): 127.     CrossRef
  • Colonoscopic Polypectomy Preferences of Asian Endoscopists: Results of a Survey-Based Study
    Dong-Hoon Yang, Bayasgalan Luvsandagva, Quang Trung Tran, Achmad Fauzi, Panida Piyachaturawat, Thida Soe, Zhiqin Wong, Jeong-Sik Byeon
    Gut and Liver.2021; 15(3): 391.     CrossRef
  • Clinical outcomes of submucosal colorectal cancer diagnosed after endoscopic resection: a focus on the need for surgery
    Yun Sik Choi, Wan Soo Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
    Intestinal Research.2020; 18(1): 96.     CrossRef
  • Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer
    Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, Jie-Hyun Kim, Ji Hyun Kim, Yang Won Min, Si Hyung Lee, Jung Ho Bae, Hyunsoo Chung, Kee Don Choi, Jun Chul Park, Hyuk Lee, Min-Seob Kwak, Bun Kim, Hyun Jung Lee, Hye Seung Lee, Miyoung Choi, Dong-Ah Park, Jong
    Clinical Endoscopy.2020; 53(2): 142.     CrossRef
  • Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer
    Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, Jie-Hyun Kim, Ji Hyun Kim, Yang Won Min, Si Hyung Lee, Jung Ho Bae, Hyunsoo Chung, Kee Don Choi, Jun Chul Park, Hyuk Lee, Min-Seob Kwak, Bun Kim, Hyun Jung Lee, Hye Seung Lee, Miyoung Choi, Dong-Ah Park, Jong
    The Korean Journal of Gastroenterology.2020; 75(5): 264.     CrossRef
  • Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer
    Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, Jie-Hyun Kim, Ji Hyun Kim, Yang Won Min, Si Hyung Lee, Jung Ho Bae, Hyunsoo Chung, Kee Don Choi, Jun Chul Park, Hyuk Lee, Min-Seob Kwak, Bun Kim, Hyun Jung Lee, Hye Seung Lee, Miyoung Choi, Dong-Ah Park, Jong
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2020; 20(2): 117.     CrossRef
  • The risk factors for delayed bleeding after endoscopic resection of colorectal tumors: a meta-analysis
    Yanqin Xu, Shishun Zhong, Wei Liang, Xiao Lu Lin
    Expert Review of Gastroenterology & Hepatology.2020; 14(11): 1083.     CrossRef
  • Clinical outcomes of endoscopic resection for colorectal laterally spreading tumors with advanced histology
    Jin-Sung Jung, Ji-Yun Hong, Hyung-Hoon Oh, Sun-Seog Kweon, Jun Lee, Sang-Wook Kim, Geom-Seog Seo, Hyun-Soo Kim, Young-Eun Joo
    Surgical Endoscopy.2019; 33(8): 2562.     CrossRef
  • Clinicopathological feature and treatment outcome of patients with colorectal laterally spreading tumors treated by endoscopic submucosal dissection
    Young-Hoon Jeong, Jun Lee, Sang-Wook Kim, Geom-Seog Seo, Hyun-Soo Kim, Young-Eun Joo
    Intestinal Research.2019; 17(1): 127.     CrossRef
  • Outcomes of ulcerative colitis‐associated dysplasia patients referred for potential endoscopic submucosal dissection
    Dong‐Hoon Yang, Jihun Kim, Eun Mi Song, Kiju Chang, Sun‐Ho Lee, Sung Wook Hwang, Sang Hyoung Park, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang
    Journal of Gastroenterology and Hepatology.2019; 34(9): 1581.     CrossRef
  • Recurrence rate of lateral margin-positive cases after en bloc endoscopic submucosal dissection of colorectal neoplasia
    Seohyun Lee, Jihun Kim, Jae Seung Soh, Jungho Bae, Sung Wook Hwang, Sang Hyoung Park, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Dong-Hoon Yang
    International Journal of Colorectal Disease.2018; 33(6): 735.     CrossRef
  • Risk factors for procedure-related complications after endoscopic resection of colorectal laterally spreading tumors
    Ji-Yun Hong, Sun-Seog Kweon, Jun Lee, Sang-Wook Kim, Geom-Seog Seo, Hyun-Soo Kim, Young-Eun Joo
    Medicine.2018; 97(41): e12589.     CrossRef
  • 5,029 View
  • 62 Download
  • 15 Web of Science
  • 14 Crossref
Close layer
Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome
Takeshi Mizukami, Shinya Sugimoto, Tatsuhiro Masaoka, Hidekazu Suzuki, Takanori Kanai
Intest Res 2017;15(2):236-243.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.236
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Colonoscopy and computed tomography (CT) are used primarily to exclude organic diseases in patients with irritable bowel syndrome (IBS), rather than to assess the pathophysiology of IBS. We aimed to evaluate colonic dysmotility and morphology in Japanese patients with IBS.

Methods

One hundred eighty-four patients with IBS and 49 asymptomatic controls who underwent colonoscopy in combination with CT colonography or barium enema were retrospectively reviewed between 2008 and 2012. Water-aided colonoscopy was performed without sedation by a single endoscopist. The duration and pattern of colonic movement and cecal intubation time were recorded. To assess colonic morphology, barium enema or CT colonography were performed immediately after colonoscopy.

Results

Colonic dysmotility was more frequent in the IBS group (28.8% vs. 2.0% in controls, P<0.001), especially in cases of IBS with diarrhea (IBS-D) (IBS with constipation [IBS-C] 28.8% vs. IBS-D 60.0% vs. mixed IBS [IBS-M] 5.1%, P<0.001). Colonic morphological abnormality was more frequent in the IBS group than in the control group (77.7% vs. 24.5%, P<0.001), especially in IBS-M and IBS-C groups (IBS-C 77.5% vs. IBS-D 48.9% vs. IBS-M 100%, P<0.001). Most patients with IBS with colonic dysmotility had experienced stress related to their symptoms. Cecal intubation time was significantly longer in the IBS group than in the control group (12.1±6.9 minutes vs. 4.6±1.9 minutes, P<0.001).

Conclusions

Unsedated colonoscopy, combined with radiographic findings, can detect colonic dysmotility and morphological abnormality. Technical difficulties observed during cecal intubation may partially explain the pathophysiology of IBS.

Citations

Citations to this article as recorded by  
  • Efficacy of Glycicumarin and Isoliquiritigenin in Suppressing Colonic Peristalsis in Both an Animal Model and a Clinical Trial
    Reo Kobayashi, Ken Inoue, Satoshi Sugino, Ryohei Hirose, Toshifumi Doi, Akihito Harusato, Osamu Dohi, Naohisa Yoshida, Kazuhiko Uchiyama, Takeshi Ishikawa, Tomohisa Takagi, Hideyuki Konishi, Yasuko Hirai, Katsura Mizushima, Yuji Naito, Yoshito Itoh
    Biological and Pharmaceutical Bulletin.2024; 47(2): 373.     CrossRef
  • Diagnostic Ability of Ultrasonography Compared with Computed Tomography for Assessing Rectal Feces
    Noboru Misawa, Masaru Matsumoto, Momoko Tsuda, Shigeki Tamura, Tsutomu Yoshihara, Keiichi Ashikari, Takaomi Kessoku, Hidenori Ohkubo, Takuma Higurashi, Hiromi Sanada, Mototsugu Kato, Atsushi Nakajima
    Journal of the Anus, Rectum and Colon.2024; 8(2): 126.     CrossRef
  • The effect of alverine citrate plus simethicone (Meteospazmyl ) on effectiveness and tolerability of bowel preparation for colonoscopy
    S.V. Kashin, D.V. Zavyalov, A.V. Sidneva
    Dokazatel'naya gastroenterologiya.2023; 12(2): 34.     CrossRef
  • Current Management of Chronic Constipation in Japan
    Tatsuhiro Masaoka
    The Keio Journal of Medicine.2023; 72(4): 95.     CrossRef
  • Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
    Shin Fukudo, Toshikatsu Okumura, Masahiko Inamori, Yusuke Okuyama, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Akiko Shiotani, Yuji Naito, Yoshiko Fujikawa, Ryota Hokari, Tastuhiro Masaoka, Kazuma Fujimoto, Hiroshi Kaneko, Akira Torii, Kei Matsueda, Hiro
    Journal of Gastroenterology.2021; 56(3): 193.     CrossRef
  • NUTRITIONAL STATUS, QUALITY OF LIFE AND LIFE HABITS OF WOMEN WITH IRRITABLE BOWEL SYNDROME: A CASE-CONTROL STUDY
    Ana Paula Monteiro de MENDONÇA, Luciana Miyuki YAMASHITA, Esther Dantas SILVA, Isabela SOLAR, Larissa Ariel Oliveira SANTOS, Ana Carolina Junqueira VASQUES
    Arquivos de Gastroenterologia.2020; 57(2): 114.     CrossRef
  • 33,552 View
  • 88 Download
  • 4 Web of Science
  • 6 Crossref
Close layer
Case Reports
Fecal microbiota transplantation for refractory Crohn's disease
Seon Ho Bak, Hyun Ho Choi, Jinhee Lee, Mi Hee Kim, Youn Hee Lee, Jin Su Kim, Young-Seok Cho
Intest Res 2017;15(2):244-248.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.244
AbstractAbstract PDFPubReaderePub

Approximately one-third of patients with Crohn's disease do not respond to conventional treatments, and some experience significant adverse effects, such as serious infections and lymphoma, and many patients require surgery due to complications. Increasing evidence suggests that specific changes in the composition of gut microbiota, termed as dysbiosis, are a common feature in patients with inflammatory bowel disease (IBD). Dysbiosis can lead to activation of the mucosal immune system, resulting in chronic inflammation and the development of mucosal lesions. Recently, fecal microbiota transplantation, aimed at modifying the composition of gut microbiota to overcome dysbiosis, has become a potential alternative therapeutic option for IBD. Herein, we present a patient with Crohn's colitis in whom biologic therapy failed previously, but clinical remission and endoscopic improvement was achieved after a single fecal microbiota transplantation infusion.

Citations

Citations to this article as recorded by  
  • Epigenetics and the role of nutraceuticals in health and disease
    Amr El-Sayed, Lotfi Aleya, Mohamed Kamel
    Environmental Science and Pollution Research.2023; 30(11): 28480.     CrossRef
  • Crohn’s disease: Etiology, pathogenesis and treatment strategies
    Izel Aycan BASOGLU, Berna KARAKOYUN
    Marmara Medical Journal.2023; 36(2): 249.     CrossRef
  • Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases
    Eva Michaud, Louis Waeckel, Rémi Gayet, Roman Goguyer‐Deschaumes, Blandine Chanut, Fabienne Jospin, Katell Bathany, Magali Monnoye, Coraline Genet, Amelie Prier, Caroline Tokarski, Philippe Gérard, Xavier Roblin, Nicolas Rochereau, Stéphane Paul
    EMBO Molecular Medicine.2022;[Epub]     CrossRef
  • Gut microbiota: A new target for T2DM prevention and treatment
    Lulu Liu, Jiheng Zhang, Yi Cheng, Meng Zhu, Zhifeng Xiao, Guangcong Ruan, Yanling Wei
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Current Trends and Challenges of Fecal Microbiota Transplantation—An Easy Method That Works for All?
    Cátia Almeida, Rita Oliveira, Pilar Baylina, Rúben Fernandes, Fábio G. Teixeira, Pedro Barata
    Biomedicines.2022; 10(11): 2742.     CrossRef
  • Bibliometric and visual analysis of fecal microbiota transplantation research from 2012 to 2021
    Fengwei Zhang, Peilin Yang, Yilin Chen, Ruirui Wang, Baocheng Liu, Jianying Wang, Min Yuan, Lei Zhang
    Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
  • Fecal microbiota transplantation for Crohn’s disease: a systematic review and meta-analysis
    F. Cheng, Z. Huang, W. Wei, Z. Li
    Techniques in Coloproctology.2021; 25(5): 495.     CrossRef
  • Management of Clostridioides difficile infection in patients with inflammatory bowel disease
    Sahil Khanna
    Intestinal Research.2021; 19(3): 265.     CrossRef
  • Microbiota and epigenetics: promising therapeutic approaches?
    Amr El-Sayed, Lotfi Aleya, Mohamed Kamel
    Environmental Science and Pollution Research.2021; 28(36): 49343.     CrossRef
  • Improving the Gut Microbiota with Probiotics and Faecal Microbiota Transplantation
    Yogita M. Patil, Rajashree B. Patwardhan, Pragati S. Abhyankar
    Journal of Pure and Applied Microbiology.2021; 15(3): 1111.     CrossRef
  • Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
    Yonghyun Lee, Nobuhiko Kamada, James J. Moon
    Advanced Drug Delivery Reviews.2021; 179: 114021.     CrossRef
  • Alteration of Gut Microbiota in Autism Spectrum Disorder: An Overview
    Donghun Oh, Keun-Ah Cheon
    Journal of the Korean Academy of Child and Adolescent Psychiatry.2020; 31(3): 131.     CrossRef
  • Development of the Korean Form of the Premonitory Urge for Tics Scale: A Reliability and Validity Study
    Mira Kim, Sang-Keun Chung, Jong-Chul Yang, Jong-Il Park, Seok Hyun Nam, Tae Won Park
    Journal of the Korean Academy of Child and Adolescent Psychiatry.2020; 31(3): 146.     CrossRef
  • Secondary causes of inflammatory bowel diseases
    Yezaz A Ghouri, Veysel Tahan, Bo Shen
    World Journal of Gastroenterology.2020; 26(28): 3998.     CrossRef
  • Fecal microbiota transplantation in the treatment of Crohn disease
    Miranda Collins, Morgan DeWitt
    JAAPA.2020; 33(9): 34.     CrossRef
  • Inflammatory Bowel Diseases: The Role of Gut Microbiota
    Cristiana De Musis, Lucia Granata, Marcello Dallio, Agnese Miranda, Antonietta G. Gravina, Marco Romano
    Current Pharmaceutical Design.2020; 26(25): 2951.     CrossRef
  • The human-microbiome superorganism and its modulation to restore health
    E. Salvucci
    International Journal of Food Sciences and Nutrition.2019; 70(7): 781.     CrossRef
  • The microbiome, cancer, and cancer therapy
    Beth A. Helmink, M. A. Wadud Khan, Amanda Hermann, Vancheswaran Gopalakrishnan, Jennifer A. Wargo
    Nature Medicine.2019; 25(3): 377.     CrossRef
  • RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention
    Jung Hoon Song, You Sun Kim
    Gut and Liver.2019; 13(1): 16.     CrossRef
  • Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery
    Michael Kriss, Keith Z Hazleton, Nichole M Nusbacher, Casey G Martin, Catherine A Lozupone
    Current Opinion in Microbiology.2018; 44: 34.     CrossRef
  • Microbiota transplantation: concept, methodology and strategy for its modernization
    Faming Zhang, Bota Cui, Xingxiang He, Yuqiang Nie, Kaichun Wu, Daiming Fan
    Protein & Cell.2018; 9(5): 462.     CrossRef
  • The hygiene hypothesis at a glance: Early exposures, immune mechanism and novel therapies
    Gabriel M. Alexandre-Silva, Pablo A. Brito-Souza, Ana C.S. Oliveira, Felipe A. Cerni, Umberto Zottich, Manuela B. Pucca
    Acta Tropica.2018; 188: 16.     CrossRef
  • The Safety of Fecal Microbiota Transplantation for Crohn’s Disease: Findings from A Long-Term Study
    Honggang Wang, Bota Cui, Qianqian Li, Xiao Ding, Pan Li, Ting Zhang, Xiaozhong Yang, Guozhong Ji, Faming Zhang
    Advances in Therapy.2018; 35(11): 1935.     CrossRef
  • Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
    Chang Soo Eun
    Intestinal Research.2017; 15(2): 145.     CrossRef
  • Diagnosis and treatment of Crohn's disease
    Hyun-Soo Kim
    Journal of the Korean Medical Association.2017; 60(6): 484.     CrossRef
  • 5,783 View
  • 60 Download
  • 24 Web of Science
  • 25 Crossref
Close layer
Crohn's disease and smoldering multiple myeloma: a case report and literature review
So Young Park, Jae Min Kim, Hyun Joon Kang, Minje Kim, Jae Joon Han, Chi Hoon Maeng, Sun Kyung Baek, Hwi-Joong Yoon, Si-Young Kim, Hyo Jong Kim
Intest Res 2017;15(2):249-254.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.249
AbstractAbstract PDFPubReaderePub

Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) that presents with abdominal pain, weight loss, and diarrhea. Although the etiology has not been fully elucidated, both environmental and genetic causes are known to be involved. In chronic inflammatory conditions such as IBD, B lymphocytes are chronically stimulated, and they induce monoclonal expansion of plasma cells, sometimes resulting in monoclonal gammopathy of undetermined significance. Immunomodulators that are commonly used to control inflammation, such as tumor necrosis factor-α (TNF-α) blockers could increase the possibility of hematologic malignancy. The pathogenesis of multiple myeloma in association with TNF-α inhibitor therapy is attributed to decreased apoptosis of plasma cell populations. Here, we describe a case of a 36-year-old male patient who was diagnosed with immunoglobulin A subtype smoldering multiple myeloma during the treatment for CD with infliximab and adalimumab. We report this case along with a review of the literature on cases of multiple myeloma that occurred in conjunction with CD.

Citations

Citations to this article as recorded by  
  • Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFα
    Ilseyar Akhmetzyanova, Tonya Aaron, Phillip Galbo, Anastasia Tikhonova, Igor Dolgalev, Masato Tanaka, Iannis Aifantis, Deyou Zheng, Xingxing Zang, David Fooksman
    Blood Advances.2021; 5(18): 3592.     CrossRef
  • Clinical Characteristics of 18 Patients with Psoriasis and Multiple Myeloma Identified Through Digital Health Crowdsourcing
    Joy Q. Jin, Jenny M. Ahlstrom, Nathan W. Sweeney, Wilson Liao
    Dermatology and Therapy.2020; 10(4): 815.     CrossRef
  • CROHN'S DISEASE AND MULTIPLE MYELOMA: A CLINICAL CASE AND LITERATURE REVIEW
    O. V. Taratina, P. A. Makarchuk, L. L. Vysotskaya
    Koloproktologia.2019; 18(3(69)): 84.     CrossRef
  • 6,737 View
  • 59 Download
  • 2 Web of Science
  • 3 Crossref
Close layer
Coexistence of ulcerative colitis and Sjögren's syndrome in a patient with Takayasu's arteritis and Hashimoto's thyroiditis
Hyun Woo Park, Hyun Seok Lee, Sejin Hwang, Han Sol Lee, Han-Ik Bae, Ghilsuk Yoon
Intest Res 2017;15(2):255-259.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.255
AbstractAbstract PDFPubReaderePub

A 31-year-old woman with a 15-year history of Takayasu's arteritis (TA) and a 13-year history of Hashimoto's thyroiditis presented with hematochezia. She received a diagnosis of Sjögren's syndrome at 1 month before her visit to Kyungpook National University Medical Center. Her colonoscopic findings were compatible with a diagnosis of ulcerative colitis (UC). She was treated with oral mesalazine, and her hematochezia symptoms subsequently disappeared. The coexistence of UC and TA has been reported; however, reports on the coexistence of UC and Sjögren's syndrome, or of UC and Hashimoto's thyroiditis are rare. Although the precise etiologies of these diseases are unknown, their presence together suggests that they may have a common pathophysiologic background. Furthermore, in patients with autoimmune or vascular diseases, including TA, systemic manifestations should be assessed with consideration of inflammatory bowel diseases including UC in the presence of gastrointestinal symptoms such as diarrhea and hematochezia.

Citations

Citations to this article as recorded by  
  • A case of seronegative primary Sjögren’s syndrome complicated by Takayasu arteritis in a Japanese girl
    Shingo Yamanishi, Yujiro Tanabe, Makoto Watanabe, Hidehiko Narazaki, Toru Igarashi, Ryuji Fukazawa, Mitsuaki Isobe, Yasuhiko Itoh
    Modern Rheumatology Case Reports.2023; 7(1): 148.     CrossRef
  • Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy
    C. Betterle, J. Furmaniak, C. Sabbadin, C. Scaroni, F. Presotto
    Journal of Endocrinological Investigation.2023; 46(4): 643.     CrossRef
  • Takayasu arteritis associated with autoimmune/inflammatory syndrome induced by adjuvants: a case-based review
    Desislava Simeonova, Tsvetoslav Georgiev, Tanya Shivacheva
    Rheumatology International.2023; 43(5): 975.     CrossRef
  • Co-existing ulcerative colitis and takayasu arteritis: A case-based review
    KaranRajgopal Kalani, AnujAchyut Ban, Sumeet Singla
    Indian Journal of Rheumatology.2022; 17(4): 416.     CrossRef
  • Takayasu’s Arteritis in a Patient With Preexisting Autoimmune Disease
    Robert Holton-Burke, Sarah Laurenzano, Susan Phillips, Laurie Bernard Stover, Suhas Radhakrishna, Manaswitha Khare
    Clinical Pediatrics.2021; 60(4-5): 210.     CrossRef
  • 7,074 View
  • 53 Download
  • 5 Web of Science
  • 5 Crossref
Close layer
Images of the Issue
An ileosigmoid fistula: what is the diagnosis?
Chun Lan Zhang, Ji Li, Yan You, Yue Hui Ni, Yan Zhang, Jia Ming Qian
Intest Res 2017;15(2):260-262.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.260
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Complex ileo‐caeco‐sigmoid fistula: a rare cause of small bowel obstruction
    Rahul Gupta, Jitendra Yadav, Lavkush Chaudhary, Rahul Varshney, Shekhar Babu, Sudhir K. Singh, Parikshit Morey, Pradip Pokharia
    ANZ Journal of Surgery.2020;[Epub]     CrossRef
  • 4,932 View
  • 41 Download
  • 1 Web of Science
  • 1 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP